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 Abbreviations  
 
Table 1 Abbreviations 
[m/v] mass per volume 
[v/v] volume per volume 
7-AAD 7-Aminoactinomycin 
A549  human adenocarcinoma cell line 
A6 cells Xenopus laevis kidney cell line 
AD/DA analog-digital / digital-analog 
AECC American-European Consensus Conference on ARDS 
AMPK adenosine-monophosphate-activated kinase 
AQP5 aquaporin 5 
ARDS acute respiratory distress syndrome 
ATI / ATII alveolar epithelial cell type I and II 
CaMKK-β Ca2+-calmodulin dependent kinase kinase β 
CD90 cluster of differentiation 90 
cDNA complimentary deoxyribonucleic acid 
CFTR cystic fibrosis transmembrane conductance regulator 
CHO chinese hamster ovary cell line 
COS-7 fibroblast-like cell line derived from monkey kidney tissue 
Deg Degenerin 
DNA deoxyribonucleic acid 
E-cadherin epithelial cadherin 
 Abbreviations  
 
ECL enhanced chemiluminescence 
EDTA ethylenediaminetetraacetic acid 
ENaC epithelial Na+- channels 
ER endoplasmic reticulum 
ERK extracellular signal-regulated kinase 
et al. et alii 
FACS fluorescence-activated cell sorting 
FBS fetal bovine serum 
FIO2 fracture of inspired oxygen 
GFP green fluorescent protein 
GRE glucocorticoid responsive element 
h hour 
H441 cells human lung adenocarcinoma epithelial cell line 
HA heme aggluttinin 
HEK-293 human embryonic kidney cell line 293 
HPRT hypoxanthin-phosphoribosyl-transferase 
HSC highly selective channels 
IAmi amiloride-sensitive current 
IFN-γ interferon-gamma 
IgG immunoglobulin G 
IKKβ inhibitor of nuclear factor kappa-B kinase subunit β 
 Abbreviations  
 
IL-1β interleukin-1β 
INa electrical current produced by transepithelial Na+-transport 
Isc electrical short circuit current 
IU international unit 
JNK c-Jun N-terminal kinase 
kDa kilo Dalton 
LB Luria broth 
LDH lactate dehydrogenase 
LPS lipopolysaccharide 
LSC low selective channel 
MAPK mitogen-activated protein kinase 
MDCK Madin-Darby canine kidney type 1 
MEC mechanosensory abnormality protein 
MG-132 proteasome inhibitor 
miRNA micro ribonucleic acid 
mmHg mm of mercury 
mRIPA modified radio-immunoprecipitation assay buffer 
mRNA messenger ribonucleic acid 
MSC mesenchymal stem cell 
N number of … 
n.s. not significant 
 Abbreviations  
 
NCBI National Center for Biotechnology Information 
Nedd4-2 neural precursor cell expressed developmentally down-regulated 
protein 4-2 
NET neutrophil extracellular traps 
NIH National Institutes of Health 
NKCC Na+,K+,2Cl- cotransporter 
P probability 
P0 open probability 
P38 p38-mitogenactivated proteinkinase 
Pa partial pressure 
PBS phosphate buffered saline 
PEEP positive end-expiratory pressure 
PKC-ξ protein kinase-C-ξ 
PY-motifs conserved proline rich sequence in all ENaC subunits  
RNA ribonucleic acid 
rpm rounds per minute 
rtPCR reverse transcription polymerase chain reaction 
SDS sodium dodecyl sulphate 
SEM standard error of the mean 
SGK1 serum- and glucocorticoid regulated kinase 
SNP single nucleotide polymorphisms 
SOC-medium salt-optimized with carbon (glucose)-medium 
 Abbreviations  
 
SP surfactant protein 
TAE Tris-acetate-EDTA-buffer 
TBS-T Tris buffered saline incl. tween 20 
TE-buffer Tris-EDTA-buffer 
TNF-α tumor necrosis factor- α 
U unit 
Ub ubiquitin 
UNC uncoordinated (protein) 
V5 epitope tag derived from paramyxovirus of simian virus 5 
VE-cadherin vascular endothelial cadherin 
VEGF vascular endothelial growth factor 
VILI ventilator-induced lung injury 
VT tidal volume 
WW-domain tryptophane rich sequence of a protein, here Nedd4-2 
YFP yellow fluorescent protein 
ZO-1 zona-occludens protein-1 
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1. Introduction 
1.1. Acute Respiratory Distress Syndrome (ARDS) 
ARDS has first been described in 1967, as a life-threatening respiratory condition 
characterized by acute onset of tachypnea, hypoxemia and loss of compliance, induced 
by different stimuli, including severe trauma, viral infection and pancreatitis (Ashbaugh 
et al., 1967). Approximately 190,000 cases and 74,000 deaths each year (mortality ~ 40 
%) are estimated for the United States alone, underlining the clinical importance of 
ARDS (Rubenfeld and Herridge, 2007).  
Until now, intensive research has been done on the mechanism and treatment of ARDS. 
The initial definition was revised in 1994 by the American-European consensus 
conference on ARDS (AECC) (Bernard et al., 1994) and further modified in the “Berlin 
Definition” in 2013 to match clinical criteria and to improve diagnosis of ARDS. The 
current definition of ARDS includes the acute onset within one week of a known 
clinical insult or new / worsening symptoms, non-cardiogenic bilateral infiltrates and 
hypoxemia, with the severity based on the degree of hypoxemia calculated as the ratio 
of oxygenation (PaO2) to the fraction of inspired O2 (FIO2) (mild ARDS: 200 mmHg < 
PaO2 / FIO2 ≤ 300 mmHg; moderate ARDS: 100 mmHg < PaO2 / FIO2 ≤ 200 mmHg; 
severe ARDS PaO2 / FIO2 ≤ 100 mmHg). Since the oxygenation is dependent on the 
ventilation of patients, these criteria have to be applied when the patient is ventilated 
with a positive end-expiratory pressure (PEEP) higher than 5 cmH2O.  
The main causes of ARDS are categorized into direct and indirect. Direct risk factors 
include all conditions that directly target the lung, such as pneumonia, inhalational 
injury or near-drowning, whereas indirect risk factors can be quite diverse. Major 
trauma, non-pulmonary sepsis, severe burns or drug overdose can all trigger ARDS 
(Ranieri et al., 2012).   
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1.1.1. Ventilation during ARDS  
Currently, there are only supportive treatment options for the different kinds of ARDS. 
These include the mode of ventilation, conservative fluid management and prone 
positioning (Guérin et al., 2013; Wiedemann et al., 2006; Young et al., 2013). PEEP 
was recognized to be effective in reducing mortality in ARDS patients already in 1967, 
while only a small subset of patients improved with steroids, antibiotics or digitalis 
(Ashbaugh et al., 1967). Especially in combination with low tidal volume ventilation it 
is highly beneficial, as it prevents the alveoli from collapsing thus keeping the lung 
open (Hickling et al., 1994). Subsequently, oxygenation is improved, even more when 
combined with fluid management (Wiedemann et al., 2006). But mechanical ventilation 
is not only beneficial for the lung. When inadequate pressures are applied, the lung can 
be damaged, a condition called ventilator-induced lung injury (VILI) (Biehl et al., 
2013), leading to increased morbidity and mortality (Parsons et al., 2005; Ranieri, 1999; 
Ranieri et al., 2000). Optimal ventilation strategies are still under debate. Studies aiming 
to elucidate the effect of lower versus higher PEEP are controversial and a meta-
analysis in 2010 came to the conclusion that only patients suffering from severe ARDS 
benefit from higher PEEP levels (Briel et al., 2010). The authors who published the 
most recent meta-analysis conclude that high PEEP levels neither reduced mortality 
before hospital discharge, nor significantly increase the risk of barotrauma but improve 
oxygenation within the first seven days of treatment (Santa Cruz et al., 2013). But not 
only the level of PEEP should be considered when determining the optimal ventilation 
settings. Another important variable in ventilating patients is the tidal volume (VT). Low 
VT ventilation has been shown to be safe compared to conventional ventilation (6 vs. 12 
ml/kg predicted body weight) (Cheng et al., 2005), minimize damage to the lung, reduce 
mortality and increase the number of days without ventilator (The Acute Respiratory 
Distress Syndrome Network, 2000) and according to a recent clinical trial it also acts 
protective on the cardiovascular system (Natalini et al., 2013).   
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1.1.2. Permissive hypercapnia 
Lung-protective ventilation with low tidal volume and reduced minute-ventilation 
(volume of air inspired per minute) leads to a decreased elimination of CO2 from the 
alveolar space, ultimately resulting in systemic hypercapnia with or without acidosis. 
Under normal conditions humans exhibit a partial pressure of arterial CO2 (PaCO2) of 
35-45 mmHg, but during several pulmonary diseases it can even exceed 200 mm Hg 
(Connors et al., 1996; Feihl and Perret, 1994; Mutlu et al., 2002; Sheikh et al., 2011). 
Clinical studies suggest that slightly elevated CO2 levels are not detrimental for the 
patients and can be accepted (Hickling et al., 1994; The Acute Respiratory Distress 
Syndrome Network, 2000). Now, permissive hypercapnia as a consequence of lung 
protective ventilation is widely accepted, although not without reservation (Curley et 
al., 2011). Several clinical studies not only show hypercapnia is not harmful, but they 
even support a beneficial effect on the lung and on survival of patients (Ryu et al., 
2012). In a rat model of systemic sepsis induced lung injury for example, hypercapnia 
only reduced the severity of lung injury when accompanied by acidosis, while buffered 
hypercapnia failed to provide any benefit (Higgins et al., 2009). This is interesting, 
because in another infection-based lung injury model sustained hypercapnia worsened 
lung injury (O’Croinin et al., 2008). Generally, hypercapnia impairs lung host defense 
in different ways. It has been shown to alter the innate immune response (Sporn et al., 
2011), but also phagocytosis (Wang et al., 2010) and generation of reactive oxygen 
species (Gates et al., 2011). 
 
pH independent effects of hypercapnia 
Positive and negative effects of hypercapnia in vivo cannot be well investigated without 
any contribution of pH. But in several in vitro models pH-independent hypercapnia 
induced mechanisms have been identified that are highly detrimental in the context of 
ARDS. Hypercapnia was shown to inhibit epithelial cell wound repair and the inhibition 
was still present, when acidosis was buffered to normal pH (O’Toole et al., 2009). 
Highly relevant is the finding, that alveolar epithelial function is significantly impaired 
during hypercapnia. This process has also been proven to be pH independent and is 
discussed in detail later (Briva et al., 2007; Chen et al., 2008; Vadász et al., 2008; 
Welch et al., 2010). Another event that has been demonstrated to be pH independent is 
blunting of the immunological response (Helenius et al., 2009).  
  
 Introduction 4 
 
1.1.3. Pathophysiology of ARDS 
ARDS is characterized by dysregulated inflammation, inappropriate accumulation and 
activity of leukocytes and platelets, uncontrolled activation of coagulation and disrupted 
epi- as well as endothelial barrier function (Matthay et al., 2012). 
Inflammation by activation of the innate immune response is triggered by microbial 
products or cell injury-associated endogenous molecules that are recognized by pattern-
recognition receptors located on the surface of the lung epithelium and alveolar 
macrophages (Opitz et al., 2010). Dependent on the cause of the disease, several other 
mechanisms can contribute to the inflammatory process, such as formation of 
neutrophil extracellular traps (NET) (Caudrillier et al., 2012) or interaction of 
inflammatory and hemostatic cells (Looney et al., 2009). Since ARDS can be induced 
by many different stimuli, inflammatory processes are not good or bad per se, but need 
fine adjustment to clear pathogens from the lung without worsening the damage.  
Another important characteristic of ARDS is the disruption of the microvascular and 
epithelial barrier causing the accumulation of protein-rich edema fluid, as well as  
leukocytes and erythrocytes in the alveolar space thereby impairing gas exchange.  
Disruption of the endothelial barrier is caused by destabilization of its major component 
vascular-endothelial cadherin (VE-cadherin) by several factors like cytokines (TNF-α, 
and IFN-γ), lipopolysaccharide (LPS) (Herwig et al., 2013) or VEGF (Chen et al., 2012) 
that are associated with different models of ARDS. Not only increased permeability of 
the endothelium is a problem in ARDS. Clinical data link obstruction and destruction of 
the microvascular bed in the lung, assessed by the pulmonary dead-space fraction, to 
increased mortality of ARDS patients (Nuckton et al., 2002). When only the endothelial 
barrier is disrupted, with the epithelium still intact, no increased permeability was 
observed and the alveolar epithelial liquid clearance was normal, indicating that a loss 
of endothelial barrier function does not necessarily induce ARDS (Wiener-Kronish et 
al., 1991).  
Less is known about the mechanism of epithelial barrier damage. In patients that died 
from ARDS a variety of events are reported to happen at the alveolar epithelium, 
including cytoplasmic swelling, vacuolization and necrosis leading ultimately to a loss 
of epithelial cells (Bachofen and Weibel, 1977). Taken into account that the epithelial 
barrier is much tighter than the endothelial barrier (Taylor and Gaar, 1970) its 
disruption is an important event in the development of pulmonary edema. Besides 
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prevention of flooding of the airspace another critical function of the alveolar 
epithelium is the precise regulation of fluid transport.  
Maximal fluid clearance has only been observed in 13 % of ARDS patients which is 
highly relevant when considering, that the hospital mortality was 62 % when fluid 
clearance was impaired or submaximal, compared to a mortality of “only” 20 % in 
patients having maximal fluid clearance rates (Ware and Matthay, 2001).    
The resolution of ARDS is quite complex and different events have to be synchronized. 
The epithelial and the endothelial barriers have to be reestablished and edema fluid, as 
well as inflammatory cells and exudate, need to be cleared from the airspace.  
1.1.4. Alveolar epithelial barrier – function and repair   
The alveolar epithelium is comprised of two different cell types: Alveolar epithelial 
cells type I (ATI) and type II (ATII). ATI cells cover approximately 93 % of the 
alveolar surface due to their large, flat morphology, thus keeping the diffusion barrier 
thin to enable proper gas exchange (Wang and Hubmayr, 2011). ATII cells are 
cuboidal, twice as abundant as type I cells and cover approximately 7 % of the alveolar 
surface. They account for 16 % of the all alveolar cells and have half of the volume of 
ATI cells (Crapo et al., 1982). Main functions are absorbance of excess alveolar fluid, a 
process later described in detail and secretion of surfactant (Kawada et al., 1990; Press 
et al., 1982). Surfactant, short for surface active agent consists of different components 
(10 % proteins, 90 % lipids) some of which reduce surface tension (surfactant proteins 
B and C (SP-B, SP-C) and phospholipids). Others play a role in host defence (SP-A and 
SP-D), underlining the immunological importance of ATII cells (Günther et al., 2001). 
Unidirectional amino acid and protein uptake from the apical side has also been 
described (Buchäckert et al., 2012; Uchiyama et al., 2008). 
In the normal lung, proliferation of this cell-type is minimal, with a reported 
proliferative subpopulation of 0.5-1 % of all ATII cells (Kalina et al., 1993). In different 
models of lung injury in rats ATII cells have been reported to function as progenitors 
for type I cells, indicating their importance in reestablishing the alveolocapillary barrier 
following lung injury by proliferation and differentiation (Adamson and Bowden, 1974; 
Clegg et al., 2005; Evans et al., 1973). In the mouse model of hyperoxia-induced lung 
injury ATII cells have been identified to promote alveolar epithelial regeneration 
(Adamson and Bowden, 1974). This process seems to be activated generally upon 
injury of the epithelium, independent of the specific stimulus. 
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Lately, evidence for pluripotent stem cells that differentiate into alveolar epithelial cells 
is rising. Those cells have been found in the adult human lung and express markers of 
mesenchymal stem cells (MSCs) like CD90 as well as pro-surfactant protein-C that is 
associated with ATII cells but can also express aquaporin 5 (AQP5), a marker of ATI 
cells. Still, it is not known whether this cell type directly differentiates into ATI or ATII 
cells or both (Chapman et al., 2011; Fujino et al., 2011).    
Repopulation of the injured epithelium and restoration of the epithelial barrier function 
alone is not sufficient to resolve ARDS. Once the epithelium is tight again, the excess 
fluid needs to be cleared from the airspace.  
Under normal conditions the alveolar surface liquid volume is precisely regulated. By 
low temperature scanning electron microscopy of the rat lung an area-weighted average 
thickness of 0.2 µm was estimated (Bastacky et al 1995). The primary regulators of the 
alveolar liquid layer are ATII cells. For many years, ATI cells have been believed to 
represent only a physical barrier, but recently studies showed that ATI cells express 
molecules crucial for fluid reabsorption and that they can as well actively contribute to 
fluid clearance (Johnson et al., 2002).   
The regulation of alveolar surface liquid volume is controlled by an orchestrated active 
absorption and secretion of Na+- and Cl-- ions, which create an osmotic driving force for 
water to follow. Key elements are epithelial Na+- channels (ENaCs) and Cl- - channels 
for example cystic fibrosis transmembrane conductance regulator (CFTR), located in 
the apical surface of alveolar epithelial cells and the Na+,K+-ATPase, a cation 
transporter located in the basolateral membrane. 
Especially in the fetal lung Cl--transport is extremely important, since it drives 
distention of the lung, enabling growth and development (Olver and Strang, 1974). The 
mechanism is independent of pulmonary vascular filtration (Carlton et al., 1992a) 
indicating that it is taking place at the alveolar epithelium. This process is described to 
be secondary active, with Cl- being cotransported into the cell by the Na+,K+,2Cl- 
cotransporter (NKCC) located in the basolateral membrane and induced by the 
electrochemical Na+-gradient created by the Na+,K+-ATPase (Carlton et al., 1992b; 
Cassin et al., 1986). This results in an excess of Cl- in the cell that is then secreted 
apically into the airspace. Around the time of birth, the predominance of Cl--secretion 
fades and Na+-absorption takes over to clear the lung from excess fluid. 
The alveolar Na+-transport is mediated by ENaCs and the Na+,K+-ATPase. As 
mentioned above, the Na+,K+-ATPase pumps Na+-ions out of the cell in exchange for 
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K+, more precisely three Na+-ions and two K+-ions. The result is a Na+-gradient 
between the airspace and the interstitium. Early studies in the rabbit urinary bladder, 
another tight epithelium exhibiting Na+-transport similar to the lung, investigating the 
properties of the apical and the basolateral membrane conclude that the Na+-
conductivity of the apical membrane is limiting the transcellular Na+-flux (Lewis et al., 
1977). This also applies to the lung (Canessa et al., 1994). 
   
 
 
 
  Figure 1 Scheme of alveolar Na+-transport 
The Na+,K+-ATPase removes Na+ from the cytosol, creating a gradient for Na+ to enter the apical side of the 
alveolar cells. This is happening both in ATI and ATII cells. Water is following the osmotic gradient that is 
created.  The result is a reduction of alveolar surface liquid. 
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1.2. Deg/ENaC superfamily 
ENaCs have first been reported from studies using frog skin and toad urinary bladder 
that were mounted in an Ussing chamber to measure transepithelial ion transport. ENaC 
or ENaC-like Na+-channels are widely distributed among different animal species. 
Molecules belonging to the Degenerin/ENaC-superfamily have been identified from 
different epithelia in nematodes (Lai et al., 1996), flies, several species of rodents 
(Canessa et al., 1994; Letz et al., 1995), frog, chicken (Goldstein et al., 1997), cow 
(Fuller et al., 1995), lungfish (Li et al., 1995) and man (Fronius et al., 2010) underlining 
the evolutionary importance of this protein family.  
1.2.1. Common structure 
All members of the Deg/ENaC superfamily share invariable topology: Two 
transmembrane domains are connected with a large extracellular loop, that contains 
cysteine-rich domains (Renard et al., 1994). The N- as well as the C-termini are located 
in the cytoplasm of the cells and represent only a small fraction of the full-length 
protein (Mano and Driscoll, 1999). Many proteins including ENaCs assemble in homo- 
or hetero-multimeric complexes with varying composition (Firsov et al., 1998; Kosari et 
al., 1998; Snyder et al., 1998).  
1.2.2. Various functions 
The functions mediated by members of the Deg/ENaC superfamily are as diverse as 
their regulation. Touch sensation in C. elegans has been shown to be dependent on the 
mechanosensory abnormality proteins (MEC-4 and MEC-10) that assemble in a 
heteromeric complex containing at least two copies of each subunit (Hong and Driscoll, 
1994; Huang and Chalfie, 1994). Proprioception is another sense that involves members 
of that family (uncoordinated (UNC-8) (Tavernarakis et al., 1997) and UNC-105 
(Garcia-Anoveros Garcia Liu)). 
Other functions of the Deg/ENaC superfamily involve neurodegeneration (Chalfie and 
Wolinsky, 1990) and sensing of protons (Chen et al., 1998). pH-dependency of ASIC 
channels in vitro required very low pH and the result was a rapidly inactivating cation 
current (Lingueglia et al., 1997; Waldmann et al., 1997). 
Most important for the elaborated study is the regulation of salt absorption controlled by 
ENaCs located in epithelial cells of the kidney, colon and lung. As published by Bentley 
in 1968 amiloride is a very potent inhibitor of ENaC (Bentley, 1968). Several types of 
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channels have been described, all of which are sensitive to amiloride namely highly 
selective channels (HSC) for Na+ and Li+ with a low conductance of 5 pS, and low 
selective channels (LSC) with a conductance of 9 pS and 28 pS (Palmer, 1992). 
1.2.3. Epithelial Na+-channels  
Four subunits have been identified in mammals, αβγδ-ENaC. The first subunit that was 
identified in the rat colon was α-ENaC (Canessa et al., 1993). When heterologously 
expressed in Xenopus oocytes, it showed characteristics that were found previously of 
channels expressed in native epithelia, namely high amiloride-sensitivity, high 
permeability for Li+ and no K+-conductivity. The only difference was that the currents 
were much smaller, compared to injection of whole colon RNA. Subsequently the 
authors searched for further subunits and found two more subunits, β- and γ-ENaC 
which, when expressed individually, did not form Na+-conducting, amiloride-inhibitable 
channels (Canessa et al., 1994). When β- and γ-ENaC were coexpressed together with 
α-ENaC, the current was more than 100 fold higher, compared to α-ENaC alone 
(Canessa et al., 1994), suggesting that α-ENaC is the pore-forming subunit whose 
properties are modulated by β- and γ-ENaC. 
δ-ENaC has been identified in 1995. This subunit shares some features with, but also 
exhibits some important differences to α-ENaC: Similar to α-ENaC, δ-ENaC expressed 
individually forms amiloride-sensitive channels and the current is increased by two 
orders of magnitude, when β- and γ-ENaC are coexpressed. Different to α-ENaC it is 
more permeable for Na+, than for Li+ and the sensitivity for amiloride was 
approximately 30 times higher (Waldmann et al., 1995). Closely related to δ-ENaC, 
functionally as well as structurally, is ε-ENaC a subunit that is exclusively expressed in 
the clawed frog  X. laevis (Babini et al., 2003).  
Although the structure of all ENaC-subunits is quite similar, the tissue expression 
pattern differs markedly. α- and β-ENaC are predominantly expressed in lung and 
kidney, whereas γ- and δ-ENaC are found in a variety of epithelial and non-epithelial 
tissues of different organs (Ji et al., 2012). δ-ENaC is expressed in heart, liver, brain and 
lung, but also found in pancreas, skeletal muscle and blood leukocytes (Su et al., 2004; 
Waldmann et al., 1995). 
The functions of β- and γ-ENaC are not as clear as for the other subunits. β-ENaC has 
been postulated to regulate trafficking of ENaC complexes to the plasma membrane. Its 
Clara cell specific overexpression in the mouse resulted in increased Na+-transport of 
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tracheal tissue that caused a cystic-fibrosis-like phenotype with mucus accumulation 
and postobstructive enlargement of distal airspaces, while overexpression of α- and γ-
ENaC did not affect Na+-transport (Mall et al., 2004). An explanation for this 
phenomenon might be that β-ENaC is normally the least abundant and thus limiting 
subunit in the lung (Farman et al., 1997; Talbot et al., 1999; Yue et al., 1995). Genetic 
knockdown studies on the other hand showed, that the fluid clearance in the lung is 
impaired, when β-ENaC expression is reduced (Randrianarison et al., 2008).  
Stochiometry of ENaC is still under debate. Generally it is believed that ENaC is a  
heterotetrameric complex composed of two α-, one β- and one γ-subunit (Firsov et al., 
1998). Using the very sophisticated approach of atomic force microscopy a trimer 
composed of one copy each of α-, β- and γ-ENaC or even a trimer-of-trimers was 
described (Stewart et al., 2011). Considering the discovery of δ- and ε-ENaC which 
might replace α-ENaC or could even be added to the conventional heteromeric complex, 
various subunit assemblies in native tissues and different in vitro models might explain 
the great variations that can be observed studying ENaC function. 
1.2.4. Regulation 
Since the control of Na+-transport is crucial to maintain proper water and salt 
homeostasis, ENaC function is tightly regulated on different levels by a variety of 
factors.  
Regulation of gene expression is limited to long term regulation and less important than 
acute effects. Significant changes of the single channel conductance due to regulatory or 
genetic changes could not be demonstrated. The predominant elements of acute ENaC 
regulation are the number of channels in the membrane (N) and their open probability 
(P0) which indicates the ratio of time the channel is in the “open” as opposed to the 
“closed” conformation (Butterworth, 2010). 
 Only a very small portion of all ENaC proteins is located in the plasma membrane. The 
vast majority is located in trafficking vesicle pools (Hanwell et al., 2002). When 
introduced into the plasma-membrane ENaCs form near-silent channels, which require 
activation by proteolytic processing of the α- and γ-subunit to be fully functional 
(Carattino et al., 2008; Sheng et al., 2006).  
Stimuli involved in ENaC regulation include hormones, especially aldosterone (Lee et 
al., 2008; Masilamani et al., 1999) and insulin (Blazer-Yost et al., 2003; Deng et al., 
2012) as well as estrogen and progesterone (Gambling et al., 2004).  
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Also, anorganic chemicals regulate ENaC activity. Na+ itself, for example, has a dual 
role on ENaC function. Intracellular Na+ has been shown to reduce proteolytic 
activation of the channel by rendering its cleavage sites inaccessible to proteases by 
changing the conformation of the complex. This process happens relatively slow (within 
minutes) and is called “feedback inhibition”. The physiologic function is to prevent the 
cells from Na+ overload and thus cell swelling (Knight et al., 2008; Komwatana et al., 
1996; Uchida and Clerici, 2002).  
Extracellular Na+ on the other hand triggers “Na+ self-inhibition”. When the 
extracellular Na+-concentration is increased rapidly, ENaC activity is impaired. In 
contrast to the feedback inhibition this response is happening within seconds, induced 
by a decrease of the open probability P0. This process can not be explained by saturation 
of Na+-transport, because increasing the Na+-concentration stepwise does not result in a 
comparable inhibition (Fuchs et al., 1977). The molecular principle of “Na+ self-
inhibition” has been shown to involve a conformational change in the proximal part of 
the extracellular loop of α- and ε-ENaC (Babini et al., 2003). Also other stimuli 
independent of Na+, like acidity, seem to act on ENaC via the “Na+ self-inhibition” as 
has been described for human ENaC (Collier and Snyder, 2009).  
Oxygen tension is an important factor in the conversion of non-seletive to high-selective  
channels. Culture of ATII cells with only 5 % O2 resulted in predominantly non-
selective channels. However after 2 h with 95 % O2 the majority of channels was highly 
selective (Jain et al., 2008). 
Chlorine has also been reported to reduce ENaC expression in the membrane and its 
activity, in the mouse as well as in isolated ATII cells (Lazrak et al., 2012).  
Further stimuli modulating ENaC activity are redox state (Downs et al., 2013; Helms et 
al., 2008) and physical factors such as shear stress (Fronius et al., 2010).  
1.2.5. Signaling pathways 
There are multiple signaling pathways that are known to regulate ENaC. Several 
steroids have been implicated in the translational regulation of ENaC, mediated 
probably via interaction with the glucocorticoid responsive element (GRE) located 
upstream of the promotor of α-ENaC (Dagenais et al., 2008). Recent studies show that 
translation of ENaC is modulated also by miRNA (Tamarapu Parthasarathy et al., 
2012). 
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Interleukin-1β (IL-1β), an important cytokine in ARDS, was shown to reduce ENaC 
mRNA levels via the P38 mitogen-activated protein kinase (MAPK) (Roux et al., 
2005). Another member of the MAP-kinase family, the extracellular signal-regulated 
kinase (ERK), is also a regulator of ENaC and has been associated with phosphorylation 
of β- and γ- ENaC. This phosphorylation is likely to enhance interaction with the E3-
ubiquitin-ligase neural precursor cell expressed developmentally down-regulated 
protein 4-2 (Nedd4-2) (Yang et al., 2006), a protein that directly attaches the small 
molecule ubiquitin to specific target proteins, leading to endocytosis and subsequent 
degradation (Kabra et al., 2008). Ubiquitination of ENaC is a highly complex 
mechanism to differentially regulate protein stability in the cytoplasm and in the plasma 
membrane. Nedd4-2 is the most prominent E3-ligase known to regulate ENaC, but there 
is evidence for other E3-ligases that interact with ENaC (Downs et al., 2013). Upon 
activation Nedd4-2, preferably its domains WW2 and/or WW3 (Itani et al., 2009), binds 
to the highly conserved PY-motifs, located at the C–terminus of all ENaC subunits, 
leading to ubiquitination of lysines located at the N-terminus of ENaC subunits, 
rendering proteins located in the cytosol susceptible for proteasomal degradation, 
whereas complexes containing αβγ-ENaC located in the plasma membrane appear to be 
targeted for lysosomal degradation (Staub et al., 1997).  
Another way of Nedd4-2 mediated ENaC regulation is a conformational change of the 
extracellular domain upon ubiquitination that impairs proteolytical processing, thus 
preventing activation of immature channels (Ruffieux-Daidie and Staub, 2010).   
Several pathways seem to converge in ubiquitination. The important effector of 
aldosterone the serum- and glucocorticoid regulated kinase (SGK1) (Debonneville et 
al., 2001; Lee et al., 2008) but also inhibitor of nuclear factor kappa-B kinase subunit β 
(IKKβ) (Edinger et al., 2009) and the metabolic sensor adenosine-monophosphate-
activated kinase (AMPK) (Almaça et al., 2009)  phosphorylate Nedd4-2, disrupting its 
interaction with ENaC.   
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1.3. State of the art 
Elevated CO2 levels have been shown to reduce alveolar epithelial function 
independently of pH by downregulation of the Na+,K+-ATPase (Briva et al., 2007). 
Further studies elucidating the underlying pathway identified AMPK to be activated 
during hypercapnia and to be involved in endocytosis of the Na+,K+-ATPase (Vadász et 
al., 2008). The exact mechanism upstream of AMPK is incompletely understood, 
especially the sensor for CO2 is still unknown.  
AMPK phosphorylates Nedd4-2 thus promoting its translocation to the membrane 
where it ubiquitinates individual or all ENaC subunits (Almaça et al., 2009; Bhalla et 
al., 2006; Myerburg et al., 2010). Ubiquitinated channels are then retrieved from the 
membrane and degraded by either the lysosome or the proteasome (Lazrak et al., 2012; 
Malik et al., 2006).  
A pharmacological study elucidating the role of several AMPK-activators on alveolar 
epithelial Na+-transport provides evidence for a differential effect of AMPK on ENaC 
and the Na+,K+-ATPase (Woollhead et al., 2007). Specific modulation of ENaC and the 
Na+,K+-ATPase by AMPK could be relevant in the resolution of pulmonary edema.   
 
Detection of ENaC proteins in the lung is difficult. Antibodies against endogenous 
proteins are poor and often recognize either the full length form or the cleaved form of 
α- and γ-ENaC (Boncoeur et al., 2009; Downs et al., 2013; Jain et al., 1999). Even if 
both forms are recognized, antibodies against each cleaved fragment produce 
inconclusive protein sizes (Albert et al., 2008). Many investigators, especially in the 
field of nephrology are working with overexpression of modified ENaC-subunits that 
can be recognized better than the endogenous proteins, but reliable systems for 
detection of ENaC protein in lung cells are not well established.       
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The aim of the present study was initially to decipher the effect of CO2 on ENaC 
function according to the working hypothesis illustrated in Figure 2. Due to 
insufficiencies of the available systems a second aim was added later:  
Establishment of a system to detect and immunoprecipitate immature and mature ENaC 
proteins in lung epithelial cells.  
       
 
 
Figure 2 Proposed mechanism of CO2 regulated endocytosis of ENaC 
CO2 is indirectly activating AMPKα1 which is phosphorylating Nedd4-2. Nedd4-2 attaches ubiquitin (Ub) to membrane 
bound ENaC to target it for endocytosis and subsequent degradation or trafficking back to the membrane. 
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2. Methods 
2.1. Cell culture 
2.1.1. Culture of A549 cells 
A549 cells show characteristics of alveolar epithelial cells and can be transfected easily. 
Cells were grown in 100 mm cell culture dishes. The full medium contained DMEM (4.5 
g/l glucose incl. stable L-glutamine) and 10 % [v/v] fetal bovine serum (FBS). No 
antibiotics were used and the cells were maintained in a humidified incubator at 37 °C, 5 % 
CO2, 100 % relative humidity.  
For treatment with high CO2-levels the medium had to be modified to compensate for the 
influence of CO2 on the pH. For that 3 ml of basal DMEM (4.5 g/l glucose incl. stable L-
glutamine), 1 ml F12-supplement and 0.5 ml of Tris-solution (0.5 M, pH 7.3 or pH 10 for 
normocapnia and hypercapnia respectively) and the solutions incubated in 5 % respectively 
18 % CO2 cell culture incubators to achieve an identical pH of 7.4 and PO2 but a PCO2 in the 
medium of either 40 or 110 mmHg, as published previously (Briva et al., 2007; Vadász et 
al., 2008). 
2.1.2. Transfection of A549 cells 
For transfection of plasmid DNA 6 x 105 A549 cells were plated on 60 mm cell culture 
plates in 3 ml of full medium. The following day 12 µl Lipofectamine 2000 were diluted in 
500 µl DMEM, incubated for 5 min, then 4 µg plasmid-DNA was added and the mixture 
incubated for 30 min. The transfection mixture was then directly added to the cells without 
aspiration of the medium. After transfection no media change was performed, since 
cytotoxicity was minimal and higher expression rates were obtained. Experiments were 
conducted 18-24 h after transfection.  
Transfection with siRNA was performed using Lipofectamine RNAiMAX. 6 x 105 A549-
cells were plated on a 60 mm cell culture dish in 2 ml DMEM. The next day cells were 
starved with preequilibrated DMEM (1.5 g/l glucose) without serum for 30 min. Per 
reaction, 17 µl siRNA and 17 µl Lipofectamine RNAiMAX were diluted in 250 µl 
OptiMEM medium each, mixed by pipetting and combined. After a 30 min incubation 
time, medium was aspirated from the cells and the 500 µl transfection solution applied to 
the cells. During a period of 4 h the cells were agitated every 15 minutes, before 1 ml of 
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OptiMEM was added. Cells were replated and transfected the next day with ENaC-
plasmids as stated above in this paragraph.    
2.1.3. Culture of H441 cells 
To elucidate the effect of hypercapnia on epithelial Na+-transport Ussing chamber 
experiments were conducted on H441 cells. H441 cells, in contrast to A549 cells, form 
polarized monolayers and are established as a model for investigation of Na+-transport in 
alveolar epithelial cells (Albert et al., 2008; Brown et al., 2008; Ramminger et al., 2004).  
The basal medium for subculturing H441 cells was RPMI 1640 incl. L-glutamine, 10 % 
[v/v] FBS, 100 IU/ml Penicillin, 100 µg/ml Streptomycin, 1 mM Na+-Pyruvat, 5 µg/ml 
Insulin, 5 µg/ml Transferrin, 5 µg/ml Na+-Selenit. 
For functional measurements cells were seeded on snapwell-inserts with a growth area of 1 
cm2. The following day the medium on the apical side was aspirated so that the apical 
compartment was exposed to air. Furthermore the medium on the basolateral side was 
supplemented with 200 nM dexamethasone. Experiments were performed 5-7 days later 
with the medium replaced every two days.  
2.1.4. Optimization of H441 cell transfection 
Transfection of H441 cells by Lipofectamine 2000 is not efficient, so another system had 
to be used. A new method designed for primary cells and hard-to-transfect cell lines is 
Nucleofection, a modified electroporation technique. Basic principle is the formation of 
pores in the plasma membrane as well as in the nuclear envelope by specifically combining 
solutions with different ionic compositions with electrical impulses of different 
frequencies, durations and intensities. The best combination has to be established 
empirically for every cell-type. 
Nucleofection was performed using a Lonza 4D-Nucleofector and preselected cell type-
specific solutions. For optimizing Nucleofection of cells in suspension H441 cells were 
cultured for 24 h. Cells were then trypsinized, counted and the appropriate amount of cells 
(1.5 x 105 cells per reaction) centrifuged at 90 g for 10 min. The supernatant was discarded, 
the cells resuspended in Nucleofection mixture (20 µl reaction: 16.4 µl Solution SF, 3.6 µl 
of supplement + 0.4 µg pMaxGFP Vector) and transferred to the Nucleofection cuvette. 
Nucleofection was conducted in the X-Unit of the device. After Nucleofection 80 µl of 
prewarmed medium was added into the cuvette to resuspend the cells and 50, 25 and 12.5 
µl of cell-suspension were plated in 150, 175 and 187.5 µl respectively of prewarmed 
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medium in a 96-well plate. 24 h after Nucleofection efficiency and viability were estimated 
and the best program selected.  
2.1.5. Transfection of H441 cells 
For transfection of H441 cells in suspension the 4D-Nucleofector System and the SF Cell 
Line 4D-Nucleofector X Kit was used.  
Cells were plated such, that they reached not more than 50 % confluence 24 h later. The 
next day cells were washed with PBS, detached from the culture plate with trypsin, 
counted and the desired amount of cells (1 x 106 cells per reaction) was centrifuged at 90 g 
for 10 min. The supernatant was discarded and the cells were resuspended in nucleofection 
solution (82 µl solution SF, 18 µl supplement), combined with the desired amount of 
nucleic acid, e.g. 2 - 4 µg pMaxGFP Vector and transferred to the Nucleofection cuvette. 
The program used for Nucleofection was CM 138. Cells were then incubated at room 
temperature for 10 min, diluted in app. 300 µl of prewarmed medium and plated. For 
transwell supports and 60 mm cell culture dishes 1 x 106 cells were plated, 0.5 x 106 cells 
for 35 mm dishes. Analysis was conducted 24 - 48 h later. 
2.1.6. Isolation of primary rat alveolar epithelial cells 
Primary rat alveolar epithelial type II cells (ATII) were isolated as described previously 
(Buchäckert et al., 2012; Dobbs, 1990) and cultured in DMEM with 4.5 g/l glucose, 10 % 
[v/v] FBS and 100 IU/ml Penicillin, 100 µg/ml Streptomycin. 
2.1.7. Establishment of ATII cell transfection 
Transfection of ATII cells was performed by Nucleofection using a Lonza 4D-
Nucleofector and preselected cell type-specific solutions as recently published (Grzesik et 
al., 2013). For optimizing Nucleofection of primary ATII cells in suspension, cells were 
cultured for 24 h. Cells were then trypsinized, counted and the appropriate amount of cells 
(1.5 x 105 cells per reaction) centrifuged at 90 g for 10 min. The supernatant was discarded, 
the cells resuspended in Nucleofection mixture (20 µl reaction: 16.4 µl Solution P1 or P3, 
3.6 µl of supplement + 0.4 µg pMaxGFP Vector) and transferred to the Nucleofection 
cuvette. Nucleofection was conducted in the X-Unit of the device. After Nucleofection 80 
µl of prewarmed medium was added into the cuvette to resuspend the cells and 50, 25 and 
12.5 µl of cell-suspension were plated in 150, 175 and 187.5 µl respectively of prewarmed 
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medium in a 96-well plate. 24 h after Nucleofection efficiency and viability were estimated 
and the best program selected.  
Further optimization revealed no loss of transfection efficiency, when using up to 3.5 x 106 
cells per 100 µl reaction. Attempts to transfect freshly isolated cells resulted in significant 
cell death.  
Some cell types that are cultured in high-calcium-medium (e.g. DMEM) require a recovery 
step after transfection to prevent an influx of calcium through the not yet closed pores in 
the plasma-membrane. For that step low-calcium-medium (e.g. RPMI 1640) is added 
directly to the Nucleofection cuvette and the cells are incubated at 37 °C for 10 minutes. 
This step proved not to be necessary for ATII cells. Also, removal of Nucleofection 
solution after transfection by diluting the cells in preequilibrated medium and subsequent 
centrifugation did not result in higher viability, nor transfection efficiency. 
2.1.8.  Final protocol for the Nucleofection of ATII cells 
For the optimized protocol freshly isolated rat AT II cells were plated in 60 mm cell 
culture dishes to recover from the isolation. The next day cells were washed with PBS, 
detached from the culture plate with trypsin, counted and the desired amount of cells (3.5 x 
106 cells per reaction) was centrifuged at 90 g for 10 min. The supernatant was discarded 
and the cells were resuspended in nucleofection solution (82 µl solution P3, 18 µl 
supplement), combined with the desired amount of nucleic acid, e.g. 3-5 µg pMaxGFP 
Vector and transferred to the Nucleofection cuvette. The program used for Nucleofection 
was EA-104. Cells were then incubated at room temperature for 10 min, diluted in app. 
300 µl of prewarmed medium and plated. For transwell supports and 60 mm cell culture 
dishes 3.5 x 106 cells were plated, 2 x 106 cells for 35 mm dishes. Analysis was conducted 
48 h later (day 3 after isolation). 
2.1.9. Flow cytometry 
For determination of transfection efficiency, cells were washed with PBS, trypsinized, 
centrifuged at 90 g and resuspended in FACS buffer (PBS without Ca2+ and Mg2+, 7.4 % 
EDTA, 0.5 % FBS, pH 7.2). To evaluate viability, cells were stained with 7-AAD (1:10) 
and incubated for 5 min prior to FACS analysis which was conducted with a LSR Fortessa 
and analyzed by FACS Diva Software.  
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2.1.10. Fluorescence microscopy 
GFP expression of transfected cells was visualized by fluorescence microscopy. Living 
cells were imaged in medium using a fluorescence microscope (Leica DMIL), a camera 
(Leica DFC 420C) and the software Leica application suite 330. 
2.1.11. Cytotoxicity assay 
Early cell death was evaluated by release of lactate-dehydrogenase (LDH) into the 
medium. Cells were transfected and plated on permeable supports as described above. The 
medium was collected at 4 h, replaced by fresh medium and collected again 24 h after 
transfection. The assay was performed as instructed by the manufacturer. Minimal cell 
death was measured in non treated cells, maximal cell death was determined by lysing cells 
with 1 % Triton X 100. 
2.2. Ussing chamber measurements 
Ussing chamber experiments were conducted on H441 cells. For those experiments cells 
were plated confluent on snapwell permeable supports. One day after plating, medium was 
removed from the apical side to culture the cells at liquid-air-interface and dexamethasone 
200 nM was added to the medium. Measurements were conducted on day 7 - 9 after 
plating. 
Experiments were performed using a custom built Ussing chamber setup. The electrical 
signal was recorded and amplified by a voltage-clamp-amplifier (custom built; Institut for 
animal physiology Gießen), converted from analog to digital by an AD/DA-converter 
(MacLab Interfaces) and recorded by a two-channel chart-strip recorder (Kipp & Zonen, 
Netherlands) plus recorded digitally using an Apple-PC, (Macintosh, Apple) and the 
software Chart (Version 3.6.3, MacLab). Electrical interference was neutralized with a 50 
Hz filter that was included in the software. The relevant data where also noted manually.   
The regular perfusion solution contained in mM: NaCl 130, KCl 2.7 KH2PO4 1.5, MgCl2: 
0.5, CaCl2, D-glucose 10. Unless otherwise stated, 55 mM Tris base was added. For 
normocapnia (pCO2 ~ 40 mm Hg) and hypercapnia (pCO2 > 100 mm Hg) the solutions 
were continuously bubbled with 5 % CO2, 21 % O2, 74 % N2 and 20 % CO2, 21 % O2, 59 
% N2  respectively and the pH adjusted accordingly to obtain a final pH of about 7.4. 
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Figure 3 Scheme of the custom build Ussing chamber.  
Both chambers of the setting were perfused seperately so it was possible to specifically target the apical or 
the basolateral compartment.   
apical basolateral 
cells 
electrodes 
perfusion 
AD converter + computer 
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2.3. Real-time rtPCR 
To study the expression of endogenous ENaC subunits on the mRNA level, real-time 
rtPCR experiments were performed. After incubating the cells in normo- versus 
hypercapnic conditions for 6 resp. 24 h, cells were lysed and mRNA isolated using the 
RNeasy-Kit according to the instructions supplied by the manufacturer. The mRNA was 
reverse transcribed (iScript cDNA Synthesis Kit (Table 2) and PCR performed with 
iTaqTM Sybr Green Supermix with ROX. The reaction composition is depicted in Table 
3. The expression of the housekeeeping gene hypoxanthin-phosphoribosyl-transferase 
(HPRT) was used to normalize the data.  
 
Calculation of data:  ΔCt = Ct housekeeping gene - Ct target gene 
             ΔΔCt = Ct CO2 – Ct control 
 
Table 2 Composition cDNA synthesis (20 µl reaction) 
component                        volume 
Reaction buffer (5x)      4 µl 
reverse transcriptase 1 µl 
RNA (1µg) x µl 
H2O to 20 µl 
  
Table 3 Composition real-time PCR (25 µl reaction) 
component volume 
iTaq Sybr Green Supermix with ROX      12.5 µl 
cDNA (1:5 diluted)            2.0  µl 
Primer forward 0.5 µl 
Primer reverse 0.5 µl 
H2O 9.5 µl 
 
Table 4 Real time PCR conditions 
initial denaturation 95°C   2:00    min 
denaturation 95°C   1:15    sec  
primer annealing + elongation 55°C   0:30    sec 
cool down   4°C      - 
35 cycles 
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Following primers were used for real-time PCR: 
Table 5 Real-time PCR Primer 
gene primer  primer-sequence reference-sequence 
α ENaC hscnn1a_F 5`-acttcagctaccccgtcagc-3´  NM_001038 
 hscnn1a_R 5`-gagcgtctgctctgtgatgc-3´  
β ENaC hscnn1b_F 5`-gcaccgtgaatggttctgag-3´ NM_000336.2 
 hscnn1b_R 5`-cggatcatgtggtcttggaa-3´  
δ ENaC hscnn1d_F 5`-cagcatccgagaggacgag-3´ NM_001130413.3 
 hscnn1d_R 5`-aggagcaggtctccaccatc-3´  
γ ENaC hscnn1g_F 5`-gctgcctactcgctccagat-3´ NM_001039 
 hscnn1g_R 5`-ttcctggacaaaggctcgat-3´  
HPRT HPRT_human_F 5`-cctggcgtcgtgattagtga-3´ NM_000194.2 
 HPRT_human_R 5`-atggcctcccatctccttc-3´  
 
2.4. Generation of genetically modified ENaC-constructs 
The expression levels of ENaC-subunits are generally low. Furthermore the majority of 
ENaC proteins is located in submembranous vesicles and in the endoplasmatic reticulum, 
making the detection of functional ENaC proteins in the plasmamembrane even more 
challenging (Hanwell et al., 2002). To enhance the expression α, β and γ-ENaC were 
cloned into expression vectors. The generated constructs were genetically modified: 
Epitope-tags were added to increase the recognition for commercially available antibodies. 
eYFP-α-ENaC-Flag, β-ENaC-V5, and Myc-γ-ENaC-HA were generated (see Table 6). β-
ENaC was the first vector generated and cloned from the human cellline A549 (see 2.1.1). 
Later, α- und γ-ENaC were cloned from previously generated plasmids (pTNT-Oocyte 
expression vector; (Fronius et al., 2010)) tagged with the respective epitope-tags and 
ligated into expression vectors.  
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Table 6 Cloning primers and genetic modifications 
protein primer primer sequence destination-
vector 
tag 
α ENaC SCNN1A_for2 5`-catggaggggaacaagct-3‘   
 SCNN1A_rev2 5´-ccttggtgtgagaaacctctcc -3`   
α ENaC SCNN1A_for3 5`-gaattcaatggaggggaacaagctggagg-3‘ pE-eYFP eYFP 
 SCNN1A_rev 5´-ggatcccttgtcatcgtcatccttgtaatcggg` 
cccccccagaggac-3`1 
 Flag 
 
β ENaC SCNN1Bfor 5`-ctcggatccacatgcacgtgaagaagtacct-3` pcDNA3.1V5/ 
Hyg 
V5 
 SCNN1Brev 5`-gcactcgaggatggcatcaccctcactgt-3`   
γ ENaC SCNN1G_forHA 5`-aggcccgaattcatggcacccggagagaagat-3` pCMV-HA-C HA 
 SCNN1G_revHA 5`-gtagccggtaccgagctcatccagcatctggg-3`   
 SCNN1G_formyc 5`-gagatcggatccaatggcacccggagagaagat-3` pCMV-tag 3 Myc 
 SCNN1G_revmyc 5`-ccccccctcgagttaagcgtaatctggaacat-3`   
  
                                               
1 Highlighted is the sequence for the FLAG-epitope-tag that was added by PCR 
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2.4.1.  Subunit-specific cloning procedure 
2.4.1.1. β-ENaC 
For the cloning of b-ENaC, mRNA was isolated from A549 cells and reverse transcribed 
into cDNA. Amplification of the coding sequence with the appropriate restriction sites 
attached was performed with Pfu-Ultra DNA polymerase. The sequence of the primers 
used is provided in Table 6. The composition of the PCR-mix is listed in Table 7, the 
cycler-conditions are given in  
Table 8.  
 
Table 7 PCR reaction β-ENaC (25 µl) 
component volume 
H2O to  25.0 µl 
buffer        2.5 µl 
dNTP        0.4 µl  
primer forward        0.5 µl 
primer reverse        0.5 µl  
cDNA        1.0 µl  
Pfu DNA polymerase        1.0 µl 
   
 
Table 8 PCR conditions for cloning of β-ENaC 
initial denaturation 97°C 10:00    min 
denaturation 95°C   1:30    min 
primer annealing 65°C   0:30    min 
elongation 72°C   4:00    min 
final elongation 72°C 10:00    min 
cool down   4°C     - 
 
The PCR-product was analyzed in a 1 % agarose-TAE-buffer gel and the fragment size 
compared to the expected size of the amplicon. 
The PCR product was purified using the Wizard® SV Gel and PCR Clean-Up System. The 
product and the vector pcDNA3.1 V5/Hyg were then digested with XhoI und BamHI at 
35 cycles 
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37°C over night (Table 9) and again purified with the PCR Clean-up System. Complete 
digestion was verified by electrophoretical determination of the fragment size.  
Table 9 Restriction digestion for b-ENaC 
component volume 
H2O +  DNA   40.0 µl 
enzymebuffer B 10x     5.4 µl 
BSA acetylated     5.4 µl 
XhoI     1.4 µl 
BamHI     1.4 µl 
 
The digested vector and a two-fold excess of insert were ligated over night at 4°C with T4 
ligase. As a negativ control the ligation was performed without insert.  
 
Table 10 Ligation reaction 
component volume 
H2O   to  20 µl 
buffer 10x         2 µl 
vector     100 ng  
insert     140 ng 
T4 ligase (3 U/µl)         1 µl 
 
2.4.1.2. α-ENaC 
Since the α-subunit of ENaC undergoes proteolytical processing during maturation, the 
two major fragments were modified to contain individual epitope tags. The primers needed 
for the modification were relatively long with a brief overlap at the coding region of the 
protein, resulting in special conditions for the PCR. Increased difficulties arose from the 
sequence of the human α-ENaC being rich in the nucleotides guanine and cytosine, 
aggrevating the cloning process. 
Therefore the plasmid was cloned in two steps. First the coding region plus some overhang 
was amplified from a preexisting plasmid (pTNT-Oocyte expression vector (Fronius et al., 
2010)) with the newly distributed Q5 polymerase which has a higher fidelity and acuracy 
compared to the Pfu-polymerase used to clone the β-subunit. The primers were designed to 
only amplify the coding region and some overhang. The PCR product of this reaction was 
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then used as a template for the next reaction, that was performed with primers that included 
restriction sites and the tag to reduce non-specific annealing. The destination vector 
pEYFP-C1 contained the epitope-tag eYFP at the N-terminus. To add another tag at the C-
terminus of the fusion protein the sequence for the FLAG-tag (5´-gat tac aag gat gac gat 
gac aag-3`) was incorporated in the reverse-primer between the coding sequence and the 
stop codon (see Table 6 highlighted).    
 
Table 11 PCR reaction for α-ENaC (25 µl) 
component volume 
H2O 15.75 µl 
buffer   5.00 µl 
dNTP   0.50 µl  
primer forward   1.25 µl 
primer reverse   1.25 µl  
cDNA   1.00 µl  
Q5 DNA polymerase   0.25 µl 
 
Table 12 First PCR condition for cloning of α-ENaC 
initial denaturation 95°C 0:30    min 
denaturation 95°C 0:10    min 
primer annealing 65°C 0:30    min 
elongation 72°C 2:10    min 
cool down   4°C  - 
 
Table 13 Second PCR condition for cloning of α-ENaC 
initial denaturation 95°C 0:30    min 
denaturation 95°C 0:10    min 
primer annealing + elongation 72°C 2:10    min 
cool down   4°C  - 
 
The PCR product and the vector were purified and digested with fast-digest restriction 
enzymes at 37°C for 15 minutes (see Table 14) and purified again for ligation. 
 
 
35 cycles 
35 cycles 
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Table 14 Restriction digestion α-ENaC (40 µl volume)  
component volume 
H2O +  DNA   32  µl 
buffer FDgreen 10x     4  µl 
EcoRI     2  µl 
BamHI     2  µl 
 
For the ligation the insert and vector were mixed at a molar ratio of 3:1 and ligated with the 
T4 ligase kit. As a negative control ligations without vector were performed.  
 
Table 15 Ligation for α-ENaC T4 ligase kit (20 µl) 
component volume 
H2O   to  20 µl 
buffer 10x         2 µl 
vector     100 ng  
insert     140 ng 
T4 ligase (3 U/µl)         1 µl 
2.4.1.3. γ-ENaC 
Cloning of the double-tagged γ-ENaC was also performed in two steps: The coding 
sequence was first amplified, ligated in the vector pCMV-HA-C, containing the c-terminal 
HA-tag and transformed into bacteria (see 2.4.2). Successful transformation was controlled 
by colony-PCR with the primer-pair SCNN1G_for/revmyc. This step provided two 
benefits: Since one primer was designed to align to a region on the first destination-vector 
the stringency for the screening was increased. Additionally, the sequence of the plasmid 
containing the HA-tag was included in the PCR-fragment, so that the PCR product could 
not only be visualized electrophoretically, but also purified and ligated directly into the 
second vector pCMV-tag 3 that added a N-terminal Myc-tag. Both PCR-reactions were 
performed with the conditions given in Table 11 and Table 13. Restriction digestion was 
performed according to Table 14, ligation as described in Table 15.    
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2.4.1.4. Site directed mutagenesis α-ENaC 
Two single nucleotide polymorphisms (SNP) were included in the original α-ENaC 
plasmid that caused a change in the aminoacid sequence (A334T and T663A) compared to 
the reference sequence NM_001038. Although they were reported earlier (rs11542844 and 
rs2228576), site directed mutagenesis was performed to eliminate possible effects on the 
biology of the protein.  
 
Table 16 Primers for site directed mutagenesis 
primer  primer sequence 
A2365G_for 
A2365G_rev 
G3352A_for 
G3352A_rev 
 
 
 
5`-gtccctgatgctgcgcgcagagcagaatgacttc-3` 
5`-gaagtcattctgctctgcgcgcagcatcagggac-3` 
5`-ggggccagttcctccacctgtcctctggg-3` 
5-cccagaggacaggtggaggaactggcccc-3` 
 
 
The mutagenesis was performed with the QuikChange Site-Directed Mutagenesis Kit. The 
reaction conditions are described in Table 17 and Table 18. 
Table 17 QuikChange site directed mutagenesis reaction 
component volume 
H2O to 25.0 µl 
buffer       2.5 µl 
dNTP       0.5 µl  
primer forward      62.5 ng 
primer reverse     62.5 ng  
Pfu Turbo DNA polymerase (2.5 U/µl)       1.0 µl 
template ( ~ 20 µg plasmid)       1.0 µl 
 
Table 18 QuikChange site directed mutagenesis thermal profile 
initial denaturation 95°C 0:30    min 
denaturation 95°C 0:30    min 
primer annealing 55°C 1:00    min 
elongation 68°C 7:00    min 
cool down   4°C  - 
 
16 cycles 
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The parental, non modified vector was digested with 1 µl DpnI at 37°C for 1 h and the 
reaction with now only the modified plasmids directly transformed into XL1-Blue 
supercompetent cells, supplied with the QuikChange Kit. For that the cells were thawed on 
ice and a 25 µl aliquot transferred to a prechilled 14 ml polypropylene tube. One µl of the 
digested DNA was added and the bacteria incubated on ice for 30 minutes, before they 
were heat-shocked at 42°C for 45 seconds and placed back on ice for 2 minutes. To 
promote bacterial proliferation 250 µl prewarmed NZY+-broth medium were added and the 
bacteria incubated at 37°C for 1 hour with shaking at 225-250 rpm. Half of the bacterial 
suspension was then plated on LB-Agar plates as described in the next chapter (2.4.2).  
2.4.2.  Transformation  
To amplify the generated plasmids for endotoxin free transfection in alveolar epithelial cell 
lines the plasmids were transformed into E. coli JM-109 by heat-shock.  
Bacteria were thawed on ice and 50 µl of the suspension were transferred to a precooled 
reaction tube. Two to 5 µl of the ligation were added and the mixture incubated for 10 min 
on ice. Bacteria were then heat-shocked for 45-50 seconds at 42°C and immediately 
incubated on ice for another 2 minutes. Now, 450 µl SOC-medium were added and the 
bacteria incubated for 1 hour at 37°C, until 100 µl were plated on LB-agar plates 
containing the appropriate antibiotic (pCMV3A und pE-eYFP: kanamycin; pcDNA3.1: 
ampicillin) to select for successfully transformed bacteria.  
2.4.3.  Plasmid preparation 
The bacterial colonies that were obtained had to be screened for containing the right, non-
modified plasmid. Small liquid cultures were prepared in 15 ml polypropylene tubes by 
inoculating 5 ml of LB-medium with bacteria picked directly from the agar-plate with a 
pipette tip, incubated over night at 37°C. Colony PCR (see Table 19) was performed to 
test for integration of the right insert with the primers used for cloning. The liquid culture 
was stored at 4°C to be able to inoculate a large scale bacterial culture and to prepare 
glycerol stocks (1:1 [v/v], stored at -80°C) for further amplification. The PCR-products 
were electrophoretically analyzed for the right size. Plasmids of promising clones were 
isolated with the Qiaprep Spin Miniprep Kit from the small liquid cultures exactly as 
instructed by the manufacturer and sent to sequencing for validation (Seqlab, Göttingen, 
Germany).   
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Table 19 PCR reaction colony-PCR (20 µl) 
Component volume 
H2O 14.4 µl 
buffer   2.0 µl 
dNTP   0.4 µl  
primer forward    0.5 µl 
primer revers   0.5 µl  
bacterial culture   2.0 µl  
Taq DNA Polymerase   0.2 µl 
 
To generate large amounts of plasmids that are needed for transfections 100 ml LB-
medium containing the appropriate antibiotic were inoculated with bacterial culture either 
from the stored mini-culture or from the glycerol stock and incubated over night at 37°C 
with shaking. Plasmids were isolated with the Qiagen Plasmid Maxi-Kit exactly as 
instructed by the manufacturer. Plasmid DNA was disolved in 200-300 µl TE-buffer, the 
concentration measured with a NanoDrop photometer and stored at -20°C.    
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2.5. Western-Immuno-Blotting 
Quantification of protein levels was done using the western-immunoblot technique. Cells 
were treated as indicated and washed three times with ice-cold PBS incl. Ca2+ and Mg2+. 
After complete removal of PBS cells were lysed with 300 µl of lysis buffer (mRIPA: 50 
mM Tris pH 8.0; 150 mM NaCl; 1 % Igepal; 1 % Na+-deoxycholate) with protease 
inhibitor cocktail (complete; 40 µl/ml) on ice for 10 min. The cell lysate was collected and 
cleared by centrifugation (10,000 rpm/10 min). Protein concentration was determined with 
the Quick-Start Bradford-Assay. Equal protein amounts were diluted in 2 x sample-buffer, 
denatured under agitation (97 °C, 350 rpm; 7-10 min) and separated electrophoretically in 
a 10 % acrylamide-gel using standard techniques. Proteins were then transferred to a 
nitrocellulose membrane with a semi-dry transfer chamber (45-60 minutes, Biorad) and 
unspecific binding sites blocked with 5 % [m/v] skim milk powder in TBS-T for 1 hour. 
After removal of blocking buffer the membranes were incubated in the primary antibodies 
at 4°C over night (see Table 20).  
 
Table 20 Antibodies for Western-Blotting 
antibody buffer dilution species company 
V5 TBST + 5 % BSA 1:2000 mouse Invitrogen 
E-cadherin TBST 1:400 rabbit Santa Cruz 
Actin TBST 1:2000 rabbit Sigma 
GFP TBST 1:1000 mouse Roche  
HA TBST 1:1000 mouse Covance 
Myc TBST 1:2000 mouse Invitrogen 
Nedd4-2 TBST 1:1000 rabbit Santa Cruz 
Flag M2 TBST 1:1000 mouse Sigma 
tGFP TBST  1:5000 rabbit Evrogen 
 
The unbound primary antibodies were removed by washing the membrane in TBS-T three 
times for 10 minutes. Membranes were then incubated with the appropriate horse-raddish 
peroxidase linked secondary antibodies (rabbit anti-mouse IgG 1:5000; goat anti-rabbit 
IgG 1:2000). Excess antibody was removed again by washing the membrane as stated 
above, drained and incubated with chemiluminescent substrate (SuperSignal West Pico). 
The signal was quantified by exposing an autoradiography film (BioMax MR or 
Amersham Hyperfilm ECL) that was developed in a Curix 60 developer. Films were 
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scanned with a CanoScan LIDE 90 and densitometry was performed with ImageJ software 
(NIH).  
In some cases the signal intensity was too low to be detected by the standard protocol. In 
these cases the concentration of the secondary antibody was reduced to 1:50,000-100,000 
and the membrane incubated with the SuperSignal West Femto substrate to obtain maximal 
detection sensitivity. 
2.6. Biotin-Streptavidin-Pulldown 
Discrimination between the total cellular amount of ENaC and the functional fraction 
located in the plasma-membrane was carried out with biotin-streptavidin-pulldown.  The 
underlying principle is the conjugation of a modified, membrane impermeable biotin to 
lysines located in the extracellular domains of membrane proteins and the subsequent 
pulldown with immobilized streptavidin that binds to biotin with high affinity (Gottardi et 
al., 1995).  
Briefly, cells were rinsed with PBS incl. Ca2+ and Mg2+ and incubated on ice with EZ-Link 
Sulpho-NHS-LC-biotin-solution (1 mg/ml in PBS) for 20 min. To quench unbound biotin 
cells were washed three times for 10 minutes with PBS containing 100 mM glycine. After 
a final washing with PBS cells were lysed as described in chapter 2.5. For each experiment 
equal amounts of protein (150-1000 µg) were incubated with 60-100 µl streptavidin-
agarosebeads at 4 °C over night in a rotator with the volume adjusted with mRIPA-buffer 
to obtain equal protein concentrations.  
The following day the beads were washed with the solutions indicated below to eliminate 
unbound proteins and proteins that were bound unspecifically. Washing solutions were 
applied, the tube inverted a couple of times, beads collected at the bottom of the tube by 
centrifugation in a mini centrifuge and the supernatant aspirated almost completely after 
each step.  
1 x solution A:   150 mM NaCl, 50 mM Tris pH 7.4, 5 mM EDTA 
2 x solution B:   500 mM NaCl, 50 mM Tris pH 7.4, 5 mM EDTA 
3 x solution C:   500 mM NaCl, 20 mM Tris pH 7.4, 0.2 % BSA [m/v] 
1 x solution Tris: 10 mM Tris, pH 7.4 
Finally the last washing solution was aspirated completely, sample buffer added and the 
samples were denatured at 99°C for 8-10 minutes. Analysis was performed as described 
above (chapter 2.5). To prove that changes were not caused by varying transfection 
 Materials and Methods 33 
 
efficiencies, total cell lysate of every sample was subjected to western blotting without 
pulldown. 
2.7. Pulse-chase-experiments 
To determine the stability of ENaC subunits located membrane, cells were biotinylated as 
stated above. After quenching the unreacted biotin with glycine cells were not yet lysed. 
Instead, preequilibrated medium was applied and cells put back in the cell culture 
incubator for up to 6 hours. After different time points the cells were washed with PBS, 
lysed with m-RIPA buffer supplemented with MG-132 (10 µM) and processed as 
described in chapter 2.6.   
2.8. Immunoprecipitation of detergent insoluble fraction of ENaC 
The cell surface expression and composition of the ENaC-complexes are strongly 
dependent on the celltype and the underlying culture conditions. Especially for kidney cell 
lines it has been reported, that the subunits aggregate to complexes that are insoluble in 
several non-ionic detergents (Prince and Welsh, 1998). To test whether this also applies to 
alveolar epithelial cell lines the detergent soluble and insoluble fractions were analysed. 
 
A549 and H441 cells were transfected and cultured for 24-48 h in the presence of 
amiloride (10 µM) to prevent cell swelling when coexpressing all three ENaC-subunits. 
Next, cells were rinsed three times with PBS containing Ca2+ and Mg2+ before cells were 
lysed in Tris-buffered saline (TBS) containing 1% Triton X-100 [v/v] and protease 
inhibitors (complete, 40 µl/ml). The insoluble fraction was pelleted by centrifugation 
16,000 g for 10 minutes at 4 °C. Supernatant was collected in another tube and the pellet 
lysed in 100 µl of solubilization-buffer (50 mM Tris (pH 7.4); 2 % SDS [w/v]; 1 % b-
mercaptoethanol [v/v]; 1 mM EDTA) at 90°C for 5 min. After heating the samples were 
diluted in 1 ml TBS containing 1 % Triton X-100. ENaC subunits were 
immunoprecipitated from both fractions with subunit specific antibodies (FLAG M2, 0.5 
µg/reaction; GFP, 2 µl/reaction) and 100 µl protein A/G beads at 4°C over night.  
Samples were finally washed three times with TBS incl. 1 % Triton X-100, denatured in 
sample buffer and further processed as described in chapter 2.5.   
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2.9. Statistical analysis and graphical illustration 
Data are presented as mean ± SEM, if not described otherwise. Statistical comparison 
between two groups was done using an unpaired Student`s t-test. Multiple data sets were 
compared by ANOVA and subsequent post hoc analysis. GraphPad prism 6 (GraphPad 
software, San Diego, CA) was used for the analysis and data presentation. Data obtained 
from Ussing chamber experiments were visualized with FreeHand 10.   
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2.10.  Materials  
Table 21  Electronic devices 
4D-Nucleofector System  Lonza, Köln, Germany 
BioPhotometer Biorad, München, Germany  
Developer Curix 60  Agfa, Mortsel, Belgium 
Electrophoresis system Biorad, München, Germany 
Galaxy MiniStar VWR, Bruchsal, Germany  
Hera Cell 150 incubator Thermo Scientific, Dreieich 
Heraeus Fresco 17 thermo centrifuge Thermo Scientific, Dreieich 
KNF Laboport Pumpe KNF Freiburg, Germany 
Magnetstirrer MR 3002 Heidolph, Schwabach, Germany  
Mettler H20T precicion scale Mettler Toledo, Gießen, Germany  
Milli-Q water purification Millipore, Schwalbach, Germany  
Mini-PROTEAN Tetra Cell  Biorad, München, Germany 
Msc-Advantage Thermo Scientific, Dreieich, Germany  
NanoDrop (ND-1000) Kisker-Biotech, Steinfurt 
Neubauer counting chamber Labor Optik, Friedrichsdorf, Germany 
PB303 DeltaRange scale Mettler Toledo, Gießen, Germany 
pH-Meter 766 Calimatic Knick, Berlin, Germany  
pipettes Gilson, Limburg-Offheim/Biohit, Rosbach, 
Germany  
Pipetus Hirschmann, Eberstadt, Germany  
Polymax 1040 Orbitalshaker Heidolph, Schwabach, Germany  
PowerPac Basic Biorad, München, Germany 
Stratagene MX 3000P Stratagene, Waldbronn, Germany  
Thermocycler Biometra T Personal Biometra GmbH, Göttingen, Germany 
Thermomix ME waterbath B.Braun Biotech, Melsungen, Germany  
Thermomoxer comfort Eppendorf, Hamburg, Germany  
Transblot SD Semi-Dry Transfer Cell Biorad, München, Germany 
VV3 vortex VWR, Darmstadt, Germany  
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Table 22 Reagents 
b-mercaptoethanol Sigma-Aldrich, Steinheim, Germany 
2-propanol Merck, Darmstadt, Germany 
7-AAD Invitrogen, Darmstadt, Germany 
A549 cells LGC, Wesel, Germany 
Agarose  Fermentas, St. Leon-Rot, Germany  
Amersham Hyperfilm ECL GE life sciences, Freiburg, Germany 
Ammoniumpersulfat (APS)  Promega, Mannheim, Germany  
Ampicillin Sigma-Aldrich, Steinheim Germany 
BamHI Fermentas, St. Leon-Rot, Germany  
BioMax MR autoradiography film Kodak (distributed Sigma-Aldrich) 
Bovine serum albumin (BSA)  Sigma-Aldrich, Steinheim, Germany 
Bromphenolblue Merck, Darmstadt, Germany  
Complete Protease Inhibitor  Roche, Basel, Switzerland 
Cytotoxicity Detection Kit (LDH) Roche, Basel, Switzerland (#11644793001) 
Dexamethasone Sigma-Aldrich, Steinheim, Germany 
DMEM 1.5 g/l glucose, stable L-glutamine PAA, Cölbe, Germany 
DMEM 4.5 g/l glucose, stable L-glutamine PAA, Cölbe, Germany  
DNAse/RNAse free water Gibco, Darmstadt, Germany  
DPBS with Ca2+ and Mg2+ PAA, Cölbe, Germany 
DPBS without Ca2+ and Mg2+ PAA, Cölbe, Germany 
E. coli JM 109 Promega, Mannheim, Germany 
EcoRI Fermentas, St. Leon-Rot, Germany 
Ethanol 70 %, 96 % and 100 % Otto Fischer GmbH, Saarbrücken, Germany  
Ethylene-diamin-tetraacetic-acid (EDTA)  Sigma-Aldrich, Steinheim, Germany  
EZ-linked-sulpho-NHS-LC-biotin Thermo Scientific, Dreieich, Germany 
F12 supplement solution Gibco, Darmstadt, Germany 
Filter paper  Biorad, München, Germany 
Glycerol  Sigma-Aldrich, Steinheim, Germany  
Glycine Sigma-Aldrich, Steinheim, Germany 
Goat anti-rabbit IgG Cell signaling, Frankfurt am Main, Germany  
H441 cells LGC, Wesel, Germany 
HCl  Carl Roth, Karlsruhe, Germany  
Igepal Sigma-Aldrich, Steinheim, Germany 
iScript cDNA Synthesis Kit Biorad, München, Germany 
iTaq Sybr Green Supermix with ROX  Biorad, München, Germany 
ITS Sigma-Aldrich, Steinheim, Germany 
Kanamycin Sigma-Aldrich, Steinheim, Germany 
KCl  Merck, Darmstadt, Germany  
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KH2PO4 Merck, Darmstadt, Germany 
LB agar Invitrogen, Darmstadt, Germany 
LB-medium Invitrogen, Darmstadt, Germany 
Lipofectamine 2000 Invitrogen, Darmstadt, Germany 
Lipofectamine RNAiMAX Invitrogen, Darmstadt, Germany 
Methanol  Sigma-Aldrich, Steinheim, Germany 
Na+-deoxycholate Sigma-Aldrich, Steinheim, Germany 
Na+-Pyruvat Sigma-Aldrich, Steinheim, Germany 
Na+-Selenit Sigma-Aldrich, Steinheim, Germany 
Na2HPO4 Merck, Darmstadt, Germany 
Na3VO4  Sigma-Aldrich, Steinheim, Germany  
NaCl Carl Roth, Karlsruhe, Germany  
NaHCO3 Merck, Darmstadt, Germany  
NaN3 Carl Roth, Karlsruhe, Germany  
NaOH Carl Roth, Karlsruhe,Germany  
Natriumdodecylsulfat (SDS)  Promega, Mannheim, Germany 
Opti-MEM Gibco, Darmstadt, Germany 
P3 Primary Cell 4D-Nucleofector X Kit Lonza, Köln, Germany 
pcDNA3.1V5/Hyg Invitrogen, Darmstadt, Germany 
pCMV-HA-C Clontech, Saint-Germain-en-Laye, France 
pCMV-tag 3 Clontech, Saint-Germain-en-Laye, France 
Penicillin/Streptomycin-mixture PAA, Cölbe, Germany 
Pfu Ultra DNA polymerase Agilent, Böblingen, Germany 
Polypropylene reaction tube 14 ml BD Falcon, Heidelberg, Germany  
Primer Metabion, Martinsried, Germany  
Protein A/G agarose beads Santa Cruz, Heidelberg, Germany  
Q5 DNA polymerase New England Biolabs, Frankfurt am Main, 
Germany 
Qiagen Plasmid Maxi-Kit Qiagen, Hilden, Germany  
Quick-Start Bradford solution Biorad, München, Germany 
QuikChange Site-Directed Mutagenesis Kit Agilent, Böblingen Germany  
Rabbit anti-mouse IgG Thermo Scientific, Dreieich, Germany 
RNeasy-Kit Qiagen, Hilden, Germany 
RPMI 1640 Gibco, Darmstadt, Germany 
SafeSeal PCR reaction tubes 0.5 und 1.5 ml Sarstedt, Nümbrecht, Germany  
SF Cell Line 4D-Nucleofector X Kit Lonza, Köln, Germany 
Snapwell permeable supports #3801 Corning, (Sigma-Aldrich, Steinheim, Germany) 
SOC Medium Invitrogen, Darmstadt, Germany 
Streptavidin-agarose beads Thermo Scientific, Dreieich, Germany 
SuperSignal West Femto substrate Pierce, Bonn, Germany  
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SuperSignal West Pico substrate  Pierce, Bonn, Germany  
SYBR Safe  Invitrogen, Darmstadt, Germany 
T4 DNA Ligase Promega, Mannheim, Germany  
Tetramethylethylendiamin (TEMED)  Carl Roth, Karlsruhe, Germany  
Transwell supports #353090 BD Falcon, Heidelberg, Germany 
Tris Base  Sigma-Aldrich, Steinheim, Germany 
Triton-X 100  Sigma-Aldrich, Steinheim, Germany 
Trypsin/EDTA PAN, Aidenbach, Germany 
Tween 20  Sigma-Aldrich, Steinheim Germany 
Wizard SV Gel and PCR Clean-Up System Promega, Mannheim, Germany 
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Table 23  Buffers 
Running buffer westernblot 1 l        
30 g Tris     
144 g Glycin     
100 ml SDS (10 %)     
Adjusted with millipore water to 1 l         
      
Transfer buffer 1 l        
                  2.45 g Tris     
                 12.20 g Glycin     
                 20.00  %               Methanol [vol/vol]     
Adjusted with millipore water to 1 l      
      
Washing buffer Tris buffered saline TBS-T pH 7.6; 1 l              
                  1.00    ml            Tween 20      
                2.42 g Tris      
                 8.00 g NaCl      
Adjusted with millipore water to 1 l, pH corrected to 7.6    
      
Sample buffer 2 x; 50 ml   10 x   
5 ml Tris 1 M; pH 6.8 6.25 ml Tris 1 M; pH 6.8 
20 ml SDS (10 %)  2.50 ml SDS (20 %) 
10 ml Glycerol 5.00 ml Glycerol (99 %) 
  Bromphenol blue   Bromphenol blue 
Adjusted with millipore water to 50 ml         
      
Stripping buffer 25 ml   
2.5 ml Glycin 1 M    
22.5 ml H2O    
250 µl HCl (37 %)     
Incubation for 1 h at room temperature with agitation   
      
Blocking buffer       
5 g  Skim milk powder      
100 ml Washing buffer     
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m-RIPA lysis buffer 100 ml     
10 ml Tris 0.5 M; pH 8   
3 ml NaCl 5 M     
1 ml Igepal (NP-40 substitute)   
1 g Na+-Dexycholat    
Adjusted with millipore water to 100 ml       
 
Tris acetic acid EDTA buffer (TAE), DNA electrophoresis 1 l      
                    4.8 g Tris    
                  57.0 ml Acetic acid    
                100.0 ml 0.5 M EDTA pH 8    
Adjusted with millipore water to 1 l, pH 8    
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3. Results 
3.1. Functional Ussing chamber measurements 
3.1.1.  pH changes of the buffer have no influence on alveolar 
Na+-transport  
To elucidate the impact of hypercapnia on alveolar Na+-transport, Ussing chamber 
experiments were performed. This technique measures the electrogenic transport of ions 
through flat tissue like bladder, frog lung, and skin or through artificial cell-monolayer.   
The electrical current detected (short circuit current (Isc)) is the sum of all ion transport 
processes. Applying pharmacological inhibitors specific for individual ion transporters or 
channels makes it possible to fractionate the Isc into different elements. Common inhibitors 
used to study Na+-transport are amiloride, that blocks epithelial Na+-channels and ouabain, 
which inhibits the Na+,K+-ATPase.   
Due to the effect of CO2 on the pH of the buffer, all solutions were buffered with Tris to 
compensate for changes of pH, when bubbled with CO2-containing gas-mixtures. Protons 
respectively acidification have been shown to regulate ENaC (Awayda et al., 2000; Collier 
and Snyder, 2009), so the first set of experiments was performed to show that the slight 
changes of pH caused by reperfusion of the solutions that were expected in this open 
system did not alter the amiloride-sensitive current IAmi. A drop of the pH from 7.4 to 7.2 
and an increase from 7.2 to 7.6 did not result in a significant change of IAmi (Figure 4). 
Controls received a constant pH buffer and time-matched amiloride applications. 
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Figure 4 Amiloride-sensitive current during pH variations 
The amiloride-sensitive current (IAmi) of polarized H441 cell monolayers was measured during different 
acidities of the Ringer‘s solution (pH: 7.2; 7.4; 7.6) in voltage clamp mode. Controls were perfused with 
Ringer‘s solution with a constant pH of 7.4 and received time-matched amiloride applications (bars show 
mean ± SEM; n = 4; *: P < 0.05). 
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3.1.2.  Hypercapnia reduces total INa 
Due to the complexity of this Ussing chamber-setting with every solution bubbled 
separately, hypercapnia could only be applied at one compartment at a time. When 
hypercapnic solution was administered at the apical compartment for 20 minutes, a 
significant decrease of IAmi was detected (Figure 5) that was absent when administered at 
the basolateral compartment (Figure 6).  
 
 
Figure 5 Apical application of hypercapnic solution 
H441 cells were exposed to normocapnic and hypercapnic Ringer‘s solution and the IAmi measured before 
and after 20 min (ami: amiloride 10 µM). Hypercapnic solution was administrated only from the apical side 
(graphs show mean ± SEM; n = 4; *: P < 0.05). 
 
 
Figure 6 Basolateral application of hypercapnic solution  
H441 cells were exposed to normocapnic and hypercapnic Ringer‘s solution and the IAmi measured before 
and after 20 min (ami: amiloride 10 µM). Hypercapnic solution was administrated only from the basolateral 
side (graphs show mean ± SEM; n = 4; *: P < 0.05).  
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3.1.3. Membrane-permeabilization experiments 
The epithelial Na+-transport is mainly the product of the activity of the Na+,K+-ATPase 
located in the basolateral membrane of polarized epithelial cells and the conductance of the 
Na+-channels, situated in the apical membrane. To locate the element(s) affected by 
hypercapnia, permeabilization studies were performed. To target only the basolateral 
membrane, all amiloride-sensitive channels were blocked, the apical membrane 
permeabilized by the antimycotic nystatin and the ouabain-sensitive current IOua measured 
after 20 min hypercapnia.  
 
 
 
 
 
 
 
During apical permeabilization a large decrease in IOua was detected indicating a strong 
inhibition of the Na+,K+-ATPase during hypercapnia (Figure 8). This is in line with 
previous findings (Briva et al., 2007; Vadász et al., 2008, 2012).  
 
Figure 7 Principle of apical and basolateral membrane permeabilization  
During apical permeabilization, Na+-channels are inhibited by amiloride and the apical membrane is 
permeabilized by nystatin, enabeling to directly measure the activity of the Na+,K+-ATPase, located in the 
basolateral membrane. During basolateral membrane permeabilization, the Na+,K+-ATPase is inhibited by 
ouabain and the basolateral membrane permeabilized by nystatin. Since the Na+,K+-ATPase usually creates 
the Na+-gradient, but is now deactivated, an artificial Na+-gradient has to be generated by the investigator. 
 Results 45 
 
 
Figure 8 Ouabain-sensitive Na+-transport during short-term hypercapnia.  
Amiloride-sensitive Na+-channels were blocked using amiloride and the apical membrane was permeabilized 
with nystatin. Next, control or hypercapnic solution was applied for 20 min and the ouabain-sensitive current 
IOua measured (graphs show mean ± SEM; n = 4; *: P < 0.05).  
 
Permeabilization of the basolateral membrane is more complex compared to 
permeabilization of the apical membrane. The Na+,K+-ATPase is inhibited by ouabain and 
the basolateral membrane permeabilized by nystatin. Since the Na+,K+-ATPase creates the 
driving force for Na+ to enter the cells, a Na+-gradient had to be generated artificially. To 
prevent a falsification of the current by Cl--ions and to stabilize the electrogenic gradients, 
Cl- -ions were substituted with the also negatively charged gluconate. The resulting IAmi, in 
the control as well as in the hypercapnia treated cells, was extremely small (Figure 9). No 
significant changes between control and hypercapnia-treated cells were detected, but due to 
the small current, an effect of CO2 can not be excluded. 
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Figure 9 Amiloride-sensitive Na+-transport during short-term hypercapnia 
Ouabain-sensitive Na+-transporter were inhibited with ouabain (1 mM) and the basolateral membrane 
permeabilized with nystatin (150 µM) and an artificial Na+-gradient was generated. 20 min later, control or 
hypercapnic solution was also applied for 20 min and the amiloride-sensitive current measured (graphs show 
mean ± SEM; n = 4; *: P < 0.05).  
3.1.4.  Long-term hypercapnia affects the apical Na+-
conductance 
To eliminate possible side-effects of the combination of additional Tris-base, artificial Na+-
gradient and Cl--substitution and to elucidate the effect of chronic hypercapnia, H441 cells 
were incubated in Normocapnia- or Hypercapnia-medium for 24 h and the 
permeabilization was repeated with the buffers published previously (Ramminger et al., 
2004; Woollhead et al., 2005) without any buffering and CO2. Interestingly, the IAmi of 
cells that were cultured in hypercapnic conditions was significantly reduced compared to 
control cells, even after approximately 30 min without CO2 (Figure 10).  
A reduction of the IAmi can either be caused by a reduced open-probability (Po) or a 
reduced number of channels in the membrane (N). Since the effect of 24 h hypercapnia 
was so stable, a change of Po alone is most unlikely. Thus the endocytic pathway was 
targeted to investigate a contribution of the change of retrieval of channels from the 
membrane. Endocytosis of ENaC has been reported to be mediated by the 5' adenosine 
monophosphate-activated protein kinase (AMPK). Attempts to use the AMPK-inhibitor 
compound C or the proteasome-inhibitor MG-132, that is also commonly used to block 
endocytosis of transmembrane proteins (Gentzsch et al., 2010; Malik et al., 2006) prior to 
subjecting the cells to hypercapnia resulted in significant cell death, probably because of 
the long incubation times of more than 24 hours.  
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Figure 10 Effect of 24 h CO2 on Na+-conductance  
H441 cells were incubated in normo- and hypercapnic conditions for 24 h. Apical permeabilization was 
performed immediately and the amiloride-sensitive current was determined (mean  ± SEM; n = 3; *: P < 
0.05).  
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3.2. rtPCR: Transcription levels of ENaC during hypercapnia 
To rule out a regulation of ENaC-subunits on the transcriptional level H441 cells were 
exposed to normocapnia and hypercapnia and mRNA was isolated after 6 or 24 hours 
(Figure 11). Real-time rt-PCR revealed no change in transcription after 6 hours for all 
human ENaC subunits. After 24 hours only the expression of the γ-subunit was 
significantly decreased, although probably not to a biologically relevant extent (Figure 
12).  
 
Figure 11 Transcription levels of ENaC subunits after 6 h CO2 
Native H441 cells were exposed to control conditions (40 mm CO2) or hypercapnia (110 mm CO2), pH 7.4 
for 6 h prior to mRNA isolation and subsequent rtPCR (Graphs represent mean, whiskers mark the 5-95 
percentile (n = 3) no significant differences were detected).   
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Figure 12 Transcription levels of ENaC subunits after 24 h CO2 
Native H441 cells were exposed to control-conditions (40 mm CO2) or hypercapnia (110 mm CO2), pH 7.4 
for 24 h prior to mRNA isolation and subsequent rtPCR (Graphs represent mean, whiskers mark the 5-95 
percentile; n = 3; unpaired Student’s t-test compared to control; *: P < 0.05).  
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3.3. Expression cloning of modified human ENaC constructs  
3.3.1. β-ENaC 
Since a pharmacological manipulation of H441 cells during 24 hours hypercapnia was not 
feasible in the Ussing chamber setting, a different model had to be established. Mall et al. 
reported that overexpression of β-ENaC is sufficient to increase the ENaC-complex 
membrane abundance and to cause a cystic-fibrosis-like phenotype in mice (Mall et al., 
2004). Thus, a modified β-ENaC was cloned and overexpressed in alveolar epithelial cells 
to enhance surface abundance of all ENaC-subunits. To improve the antibody recognition 
of the overexpressed β-ENaC construct, the epitope-tag V5 was added to the C-terminus 
(Figure 13).  
 
 
Figure 13 β-subunit of the human epithelial Na+-channel was cloned from human lung tissue  
The coding region corresponds to the NCBI Reference Sequence NM_000336.2. The epitope-tag V5 was 
added at the C-terminus, resulting in a predicted size of 96 kDa.  
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3.3.2.  Cell surface abundance of β-ENaC-V5 
To assess whether experimental difficulties using the buffered Ussing chamber solution 
rendered the effect of CO2 on ENaC invisible, the newly generated β-ENaC-V5 construct 
was transfected in A549 cells and the cell surface abundance and total cellular content was 
investigated by cell surface biotinylation. After one hour of hypercapnia no changes of the 
surface or total ENaC fraction were detected (Figure 14).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14 Short-term effect of CO2 on β-ENaC-V5 
A549 cells were transiently transfected with β-ENaC-V5. 24 h later the cells were subjected to normocapnia 
or hypercapnia for 1 hour and the β-ENaC-V5-levels were determined. (A) Biotin-streptavidin pulldown was 
performed to assess cell surface abundance of β-ENaC-V5. (B) Whole cell lysate of the same samples was 
blotted to determine total β-ENaC-V5 content (n = 4). 
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In the functional studies a significant decrease of the INa was detected (Figure 10). 
Consequently, cell surface expression of β-ENaC-V5 was also investigated after 24 h 
hypercapnia. In line with the functional studies a marked decrease of the cell surface 
abundance could be observed that was not caused by generally lower total ENaC content 
(Figure 15). Pharmacological intervention using the endocytosis and proteasome inhibitor 
MG-132, the lysosome inhibitor chloroquine or the AMPK-inhibitor Compound C 2 hours 
before and during the 24 h hypercapnia incubation resulted again in significant cell death.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 15 Long-term effect of CO2 on β-ENaC-V5 
A549 cells were transiently transfected with β-ENaC-V5. Four hours later, cells were subjected to 
normocapnic (control) conditions or hypercapnic (CO2) for 24 h. (A) Biotin-streptavidin pulldown was 
performed to assess cell surface abundance of β-ENaC-V5. (B) Whole cell lysate of the same samples was 
blotted to determine total β-ENaC-V5 content (n = 5; *: P < 0.05).  
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3.3.3.  Expression cloning of human α- and γ-ENaC 
Against the above mentioned evidence from the literature (chapter 1.3) no acute regulation 
of β-ENaC was observed. A possible explanation for that could be a different processing of 
individually expressed ENaC-subunits compared to a system in which all three subunits are 
expressed simultaneously, as reported for other cell types (Hughey et al., 2003). Thus, α- 
and γ-ENaC constructs were generated. Since both subunits undergo proteolytic processing 
during maturation, each subunit was tagged individually at the N-, as well as the C-
terminus with different epitope tags (Figure 16) to provide a powerful tool for studying all 
aspects of post-translational ENaC-regulation, including but not limited to ubiquitination, 
phosphorylation and binding to the E3-ubiquitin ligase Nedd4-2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 16 Overview about all ENaC-plasmids that were generated as part of this study  
Expected sizes are given of the full length (top) as well as of the mature fragments (bottom) with the genetic 
modifications. Modified from R. Hughey (Hughey et al., 2003) 
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Figure 17 Expression pattern of α-ENaC before and after site-directed mutagenesis 
The α-ENaC clone number 9 contained two single nucleotide polymorphisms (A334T, T663A), compared to 
the reference sequence NM_001038 (genebank, NIH), which were corrected using site-directed mutagenesis. 
The modified clone 9.2.1 contains a coding region identical to the reference sequence and does not exhibit 
alternative cleavage pattern when expressed individually in A549 cells (antibody used: anti-GFP, Roche).   
 
α, β and γ-ENaC could be expressed in A549 cells. The membrane abundance however 
was very variable and in many cases too low to be detected, even with the most sensitive, 
non-radioactive detection methods available for western-blotting. Further, cotransfection 
with plasmid amounts in the sublethal range resulted in only very low expression levels of 
α and γ ENaC.  
Trafficking of fully assembled ENaC-complexes to the cell membrane that are insoluble in 
the generally used non-ionic detergent-containing lysisbuffers were reported for different 
types of kidney cells (Prince and Welsh, 1998). Additionally a localization of ENaC in 
lipid rafts has been described in the mouse and frog kidney cells, also rendering it insoluble 
in the above mentioned buffers (Hill et al., 2007). An experiment was designed to evaluate, 
whether this was also the case for A549 cells, which exhibit formation of lipid rafts (Song 
et al., 2007). α-ENaC alone and α, β and γ-ENaC together were transfected in A549 cells 
and the abundance of α-ENaC in the soluble fraction was compared to the insoluble 
fraction.  
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As can be seen in Figure 18 α-ENaC was expressed when transfected alone and together 
with β and γ (A: lanes 2a, 3a; whole cell lysate, Triton X-100 soluble). An 
immunoprecipitation was performed to compare the abundance of α-ENaC in the Triton X-
100 soluble (b) and insoluble fraction (c) of the same cell lysate. Only faint bands were 
detected in the insoluble fraction (lane 2c), suggesting ENaC not to be present in lipid rafts 
in A549 cells. As a positive control for succesful immunoprecipitation also the soluble 
fractions were subjected to immunoprecipitation (b), which led to a distinct pull down (A 
and B; lanes 2b, 3b) that was detectable even after a brief exposure. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 18 ENaC localisation in soluble fraction and in lipid rafts in A549 cells. 
 Cells were transfected without plasmid (1), α-ENaC-YFP alone (2) or α-ENaC-YFP, β-ENaC-V5, γ-ENaC-
HA combined (3) and lysed in TBS containing 1% Triton X-100. The insoluble pellet was boiled in 
solubilization buffer containing SDS and β-mercaptoethanol and diluted in TBS containing 1% Triton X-100. 
Total cell lysate is presented in the first three lanes (a, 50 µg protein). Immunopreciptation was performed 
either from the Triton X-100- (b, ~ 600 µg protein ), or the SDS-soluble fraction of the same amount of cells 
(c). Two different exposure times are shown to focus either on the total cell lysate (A) or the 
immunoprecipitated fraction (B). Depicted is a representative of three independent experiments.  
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Protein-turnover especially of ENaC is significantly influenced by the system used and the 
culture conditions. Before using the system to study the effect of CO2, the baseline stability 
of cell surface α-ENaC was determined by pulse-chase experiments. For that, all 
membrane proteins are labeled with the membrane impermeable EZ-linked-sulpho-NHS-
LC-biotin and the cells incubated again in preequilibrated medium for the duration 
indicated. After that the cells were lysed and remaining α-ENaC precipitated with 
streptavidin-agarose beads. A half-life of α-ENaC, inserted in the plasma-membrane of 
about 2 h was measured. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 19 Stability of cell surface α-ENaC-YFP transfected in A549 cells 
All proteins located in the plasma-membrane were labeled with biotin. The cells were then covered with 
preequilibrated medium and returned to the cell culture incubator. After the indicated time-points, cells were 
harvested, subjected to biotin-streptavidin pulldown and the remaining fraction of labeled α-ENaC-YFP was 
determined by western-blotting (means ± SEM, n = 3). 
 
If CO2 was a stimulus for ENaC to be retrieved from the plasma-membrane, decreased 
stability of the membrane fraction was to be expected. To adress this, membrane-proteins 
were biotinylated as described above, but the cells incubated in normocapnia or 
hypercapnia medium for 2 and 4 hours (Figure 20). 
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Observed was a slightly but not significantly decreased stability of α-ENaC during 
hypercapnia (Figure 20).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 20 Stability of surface α-ENaC during normocapnia and hypercapnia 
All membrane proteins were labeled with biotin. The cells were then covered with preequilibrated 
normocapnia (N) or hypercapnia (H) medium and returned to the cell culture incubator. After the indicated 
time-points, cells were harvested, subjected to biotin-streptavidin pulldown and the remaining fraction of 
labeled α-ENaC-YFP was determined by western-blotting (mean ± SEM, n = 3). 
 
 
Degradation of ENaC is catalyzed by the E3-ubiquitin ligase Nedd4-2 (Itani et al., 2009; 
Kabra et al., 2008; Malik et al., 2005), and therefore it is anticipated, that its genetic 
inhibition should increase the total levels of ENaC and prevent the accelerated degradation 
during hypercapnia.  
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As depicted in Figure 21, the genetic inactivation of NEDD4-2 was highly effective. 
 
 
 
 
 
 
 
Figure 21 Nedd4-2 dependent cell surface expression of α-ENaC-YFP 
(A) Nedd4-2 was efficiently downregulated by siRNA transfection (representative blot of 5 experiments).  
 
The faster degradation of α-ENaC-YFP during hypercapnia was completely abolished 
when Nedd4-2 was silenced. Still, degradation of ENaC located in the plasma membrane 
was observed and the rate of degradation did not differ from cells that were expressing 
Nedd4-2 (Figure 22) . This finding did not correspond to the efficiency of the knockdown, 
which was reproducibly highly efficient.  
NEDD4-2 
siRNA control 
Vinculin 
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Figure 22 CO2 dependent stability of α-ENaC-YFP during silencing of Nedd4-2.  
The E3-ligase Nedd4-2 was silenced by siRNA transfection. The stability of α-ENaC-YFP was then 
compared after 4 hours of normocapnia or hypercapnia in the cell surface (A) and in the whole cell lysate (B) 
(mean ± SEM, n = 3).   
 
3.3.1. Transfection of H441 cells 
Compared to A549 cells, H441 cells are more widely used for studying Na+-transport 
(Albert et al., 2008; Ramminger et al., 2004). Transfection of H441 cells with a new high-
end 4D-Nucleofector-system was established to circumvent the poor antibodies raised 
against the endogenous ENaC subunits. The process called Nucleofection is based on 
electroporation and provides an elegant and fast technique for delivering nucleic acids 
directly into the nucleus.  
After optimization of the Nucleofection H441 cells could efficiently be transfected ( 
 
 
Figure 23). A mean transfection efficiency with the GFP control-plasmid pMaxGFP of  ~ 
60 % was achieved (Figure 24).   
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Figure 23 GFP expression of transfected H441 cells 
H441 cells (1 x 106 cells/reaction) were nucleofected with and without 4 µg pMaxGFP. Depicted is a typical 
of seven independent experiments. 
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100 µm 100 µm 
0 µ pMaxGFP 4 µg pMaxGFP 
 
Figure 24 Transfection efficiency of H441 cells achieved by nucleofection 
H441 cells (1 x 106 cells/reaction) were nucleofected with 4 µg pMaxGFP plasmid and the efficiency was  
determined by flow cytometry gating for GFP-positive cells (mean ± SEM; n = 3; ****: P < 0.0001 ).  
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Cotransfection of α, β and γ-ENaC was also succesful, as shown in Figure 26. Every 
subunit was detected in the same cell lysate using the subunit specific antibodies (α: GPF, 
β: V5, γ: HA). The transfection was transient, with fusion proteins being detectable after 
24 hours but with a marked decrease in whole cell protein levels already after 48 hours.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 26 Cotransfection of α β and γ-ENaC in H441 cells 
H441 cells were cotransfected without DNA (c) and with α-ENaC-YFP, β-ENaC-V5, γ-ENaC-HA (t) and  
lysed 24 h respectively 48 h later and analysed by western immunoblotting using antibodies against the 
respective epitope tags. 
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Figure 25 Viability of H441 cells after Nucleofection 
H441 cells (1 x 106 cells/reaction) were nucleofected with 4 µg pMaxGFP plasmid, stained with the dye 7-
AAD and the viability was  determined by flow cytometry  (mean ± SEM, n = 3).  
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However, detection of α and γ-ENaC in the cell membrane remained suboptimal. To 
optimize the cell surface expression of this two subunits, α and γ-ENaC constructs, both 
eGFP-tagged for recognition with the same antibody (Figure 27), were transfected in 
H441 cells and analyzed (Figure 28). Surface expression of α and γ-ENaC was evanescent, 
considering that the pulldown was performed from 1.8 mg total protein (surface) and the 
amount of total cell lysate that was loaded (50 µg / lane; (total)). The chemiluminescent 
signal was developed with the Supersignal West Femto substrate for maximal sensitivity. 
Treatment of the cells 5 days prior transfection and after transfection with dexamethasone, 
as well as aspiration of the apical liquid to expose the cells to air, did not increase the 
expression levels within the time-course of plasmid-expression (24 hours, data not shown).   
 
 
 
 
Figure 27 Scheme of the commercially available tGFP-tagged α- and γ-ENaC constructs (Origene) 
used in this study 
Predicted sizes are given of full length forms (top) and after proteolytical processing (bottom). 
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Figure 28 Expression pattern of α and γ-ENaC in the cell-surface of H441 cells 
Combinations of different ENaC-subunits were cotransfected in H441 cells and the cell membrane 
abundance compared  to the whole cell content of α and γ-ENaC (anti-tGFP). Shown is a biotin-streptavidin-
pulldown of 1800 µg total protein (membrane) and 50 µg whole cell lysate.   
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3.3.2.  Transfection of primary rat alveolar epithelial cells 
Primary cells are in many ways superior to immortilized or tumor cell lines and represent a 
more physiologic system to study Na+-transport. However, immunological detection of 
ENaC has always been difficult in primary cells. Another caveat is that genetic 
manipulation of primary cells by gene silencing and overexpression was usually associated 
with virus-mediated gene transfer, resulting in non-conventional experimental procedures 
that were limited by safety-regulations and complex and labour-intensive virus-production. 
As a proof of principle, ATII cells were transfected with Lipofectamine 2000 basically as 
described before (2.1.2). The amount of DNA per transfection was increased to achieve the 
same ratio of DNA to cells, as with Nucleofection. Subsequently, the amount of 
Lipofectamine 2000 was adjusted. The transfection resulted in only a few transfected cells, 
as depicted in Figure 29, confirming the dogma, that ATII cells can not efficiently be 
transfected by non-viral techniques.  
 
 
Figure 29 Lipofection of ATII cells 
ATII cells were plated on 60 mm cell culture plates and allowed to recover for one day. They were then 
transfected with 15 µl Lipofectamine 2000 without or with 5 µg of the vector pMaxGFP. GFP expression 
was assessed 2 days later by fluorescence microscopy (n = 3). 
 
Nucleofection is a transfection method, specifically designed for primary cells and other 
cells that are hard to transfect. This also applies to ATII cells, therefore a protocol was 
created to transfect them. For the first time a safe, reliable and efficient transfection 
procedure based on electroporation was established as part of this thesis to genetically 
manipulate primary ATII cells. Nucleofection proved to be dose-dependent, as depicted in 
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Figure 30 and Figure 31. The transfection efficiencies for 3, 5 and 8 µg pMaxGFP were 
32.4 ± 0.5, 39.6 ± 1.2 and 48 ± 0.7 % respectively (Figure 31). 
 
 
Figure 30 Nucleofection of primary rat alveolar epithelial type II cells. 
Freshly isolated ATII cells were allowed to recover over night on a cell culture dish. The next day 3.5 x 106  
cells were transfected with up to 8 µg pMaxGFP plasmid. The negative control was pulsed as all other cells, 
but without plasmid DNA and results were visualized 48 hours after transfection.  
 
Figure 31 Transfection efficiency of ATII cells  
Freshly isolated rat alveolar epithelial type II cells were allowed to recover on culture dishes over night, 
transfected with pMaxGFP (3-8 µg/reaction) and plated onto permeable supports at a density of 3.5 x 106 per 
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filter. Efficiency was assessed two days after transfection. (A) Scatter plot of GFP expression measured by 
FACS analysis. (B) Transfection efficiency of AT II cells transfected with the indicated DNA-amounts (bars 
indicate mean ± SEM; n = 2-3; ****: P < 0.0001 ). 
 
Cells transfected with 8 µg DNA took longer to attach to the transwell-membrane after 24 
h. To rule out early cell death due to the transfection procedure lactate-dehydrogenase 
(LDH) release was measured 4 and 24 h after transfection. After 4 h a strong release of 
LDH was detected only in cells that received the electrical pulse, which returned to 
baseline 20 h later. This LDH release is the result of the formation of pores in the cell 
membrane, which are the reason for delivery of nucleic acids by Nucleofection. At the later 
timepoint no significant LDH was measured (Figure 32). Counting the number of cells 
that remained on the permeable support 48 h after Nucleofection showed no significant 
differences (Figure 33). 
However, viability was not significantly decreased 48 h after transfection compared to 
control cells as assessed by flow cytometry (Figure 34) and the cells formed electrically 
tight monolayers with a resistance of about 1200 Ω * cm2, that did not differ from each 
other (Figure 35).  
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Figure 32 Evaluation of early cytotoxicity in transfected ATII cells 
ATII cells were transfected as indicated and plated onto permeable supports. Four (patterned bars) and 24 h 
(full bars) after transfection medium was removed, cleared from cells and subjected to a lactate-
dehydrogenase assay to screen for cell damage (mean ± SEM; n = 3; *: P < 0.05). 
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Figure 34 Viability of transfected ATII cells. 
Rat alveolar epithelial type II cells were transfected with pMaxGFP, plated onto permeable supports at a 
density of 3.5 x 106 per filter. Control cells were sham transfected without the vector pMaxGFP but 
otherwise received the same treatment as cells receiving the GFP vector pMaxGFP (3-8 µg / reaction). Two 
days after transfection cells were trypsinized, stained with 7-AAD and subjected to flow cytometry. (A) 
Scatter plot of flow cytometry showing live cell population (inside the box). (B) Viability of transfected cells 
(bars indicate mean ± SEM; n = 3-4). 
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Figure 33 Cell number 48 h after Nucleofection 
ATII cells were transfected as indicated, maintained for 48 h, trypsinized and the number of attached cells
counted for each experimental condition (mean ± SEM; n = 3). 
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Figure 35 Electrical resistance 48 h after Nucleofection 
Two days after Nucleofection the electrical resistance of the ATII cell monolayer was measured with an 
volt ohm meter (bars indicate mean ± SEM; n = 3). 
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3.3.3. ENaC transfection in ATII cells 
To translate the newly established system to the initial project of studying ENaC and its 
regulation during hypercapnia α- and β-ENaC individually and αβγ-ENaC together were 
transfected into ATII cells. In the first experiments expression was evaluated two days 
after Nucleofection, but no signals were detected (not shown). When the analysis was 
carried out already after one day, relatively strong expression of individually transfected α- 
and β-ENaC was detected and faint bands in the cotransfected sample. The low amount of 
protein that was available might explain the absence of γ-ENaC (Figure 36). Of note: Due 
to the low yield of protein the biotin-streptavidin pulldown was performed from only up to 
200 µg protein and only 10-16 µg protein of whole cell lysate was blotted, as opposed to 
1.8 mg that were used for the pulldown in H441 cells (chapter 3.3.1).  
b-V5          à 
α-tGFP      à 
E-cadherin à 
membrane       ǀ      whole cell lysate 
+   +   γ-tGFP 
+ + + + b-V5 
+         
+   + pMaxGFP 
α-tGFP + + + 
Figure 36 Pilot experiment for transfection of ENaC subunits in ATII cells 
Freshly isolated ATII cells were allowed to recover from isolation for 1 day. They were then transfected 
as indicated (equal ratios of subunits, total amount of DNA always 8 µg) and expression of recombinant 
ENaC subunits was monitored 24 h after transfection. Pulldown was performed from up to 200 µg protein 
and whole cell lysate shows 10 – 16 µg protein.  
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4. Discussion 
4.1. Hypercapnia modulated regulation of alveolar Na+- transport  
The alveolar fluid transport is tightly regulated in the intact lung due to secondary active 
Na+-reabsorption creating an osmotic gradient for water to follow passively. The two key 
molecules involved in Na+-transport are the Na+,K+-ATPase that actively exchanges Na+ 
for K+, thus lowering the intracellular Na+-concentration. This drives Na+ from the alveolar 
space to passively enter the cells through ENaCs (Matthay et al., 2002).   
During different respiratory diseases ventilation is impaired leading to a reduced 
elimination of CO2 in the body, a condition called hypercapnia. Hypercapnia can also be a 
consequence of lung protective ventilation during ARDS (Hickling et al., 1994).  
Despite its immunoregulatory function hypercapnia has been reported to negatively affect 
alveolar fluid transport independent of pH. This finding has been reported from rats in 
vivo, isolated rat lungs as well as from isolated epithelial cells (Briva et al., 2007). The 
underlying mechanism is a CO2 - triggered rapid increase in cytosolic Ca2+. This leads to a 
Ca2+-calmodulin dependent kinase kinase β- (CaMKK-β) mediated phosphorylation of the 
α-subunit of AMPK. One of the distal elements of this signaling cascade is protein kinase-
C-ξ (PKC-ξ) which directly phosphorylates the α-subunit of the Na+,K+-ATPase at serine-
18, leading to its endocytosis (Briva et al., 2007; Vadász et al., 2008). Phosphorylation of 
serine-18 has been shown to induce ubiquitination of the α-subunit of the Na+,K+-ATPase 
during hypoxia, so this is likely also the case in hypercapnia (Dada et al., 2007). Activation 
of AMPK was also shown to be dependent on extracellular-signal regulated kinase (ERK) 
activation. 
In the present study, the effect of hypercapnia on Na+-transport in H441 cells has been 
tested in Ussing chamber experiments. To rule out any contribution of pH changes, an 
initial experiment was performed, showing that variations of pH in the range of 7.2 – 7.6 
did not influence the Isc. All other experiments were performed at a pH of 7.4. In line with 
the investigations mentioned above, hypercapnia resulted in a pronounced decrease in the 
total Na+-transport which was caused by a strong inhibition of the Na+,K+-ATPase activity, 
as assessed by membrane permeabilization, supporting the established role of the Na+,K+-
ATPase in hypercapnia. Interestingly this decrease was only present when hypercapnic 
solution was perfused in the apical compartment.  
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An explanation could be a distinguished difference in the CO2 permeability of the apical 
and basolateral membrane caused for example by different subsets of transmembrane 
proteins, in especially gas permeating channels. Aquaporin 1 (AQP1) was demonstrated to 
be a physiologically relevant candidate to conduct CO2 (Boron, 2010; Musa-Aziz et al., 
2009; Wang et al., 2007) but its significance as a gas channel is highly controversial. A 
study using AQP1 deficient mice did not yield any differences in the CO2 transport rate of 
the alveolo-capillary barrier (Fang et al., 2002). Additionally, AQP1 in the lung is 
predominantly expressed in endothelial cells (Jiao et al., 2002; King and Agre, 2001; King 
et al., 2002), so a potential differential expression pattern of AQP1 in the apical and 
basolateral membrane of H441 cells cannot be the reason for the absence of basolateral 
CO2 mediated modulation of INa. Other channels that conduct CO2 are AQP4 and AQP5 
and AQP 5 is indeed expressed in ATI cells (Verkman et al., 2000). Another possibility 
could be an interference of the permeable support with the exposition of the cells to CO2. 
These possibilities are currently under investigation in our laboratory.  
Interestingly, many elements of the signaling cascade that induces downregulation of the 
Na+,K+-ATPase are also known direct or indirect regulators of ENaC function. 
 
 Figure 37 CO2 induced signaling cascade leading to endocytosis of the Na+,K+-ATPase 
Elements proven to regulate ENaC are highlighted in red. 
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ERK has been shown to phosphorylate β- and γ-ENaC thereby mediating interaction with 
Nedd4-2 ultimately resulting in endocytosis and reduction of P0 (Shi et al., 2002). Also α-
ENaC expression and additionally alveolar Na+-transport have been shown to be regulated 
in an ERK dependent manner (Frank et al., 2003). 
PKC mediates liquid regulation in the rat lung (Soukup et al., 2012). Also other groups 
report PKC-dependent ENaC regulation (Awayda et al., 1996; Shimkets et al., 1998; 
Stockand et al., 2000), but the CO2-activated ξ-isoform has never been directly linked to 
ENaC. 
JNK on the other hand has been shown to phosphorylate the E-3 ligase Nedd4-2, which is 
known to ubiquitinate ENaC, causing its inhibition (Hallows et al., 2010). 
AMPK dependent ENaC regulation has been extensively investigated. Activation of 
AMPK leads to decreased ENaC function and thus alveolar fluid clearance (Albert et al., 
2008; Carattino et al., 2005; Myerburg et al., 2010; Woollhead et al., 2007). Two 
mechanisms seem likely to happen upon activation of AMPK: The classical way of 
interaction involves AMPK-dependent association of Nedd4-2 with ENaC subunits that 
induces retrieval of the channel from the membrane and thereby limiting Na+-transport 
(Bhalla et al., 2006; Carattino et al., 2005). Another way of AMPK-dependent ENaC 
regulation is a reduction of single-channel P0 rather than an effect on N as shown in H441 
cells (Albert et al., 2008).  
Since all these elements are activated during hypercapnia and are associated with ENaC 
regulation, the effect of CO2 on ENaC function was investigated as part of the present 
study. As mentioned above, total Na+-transport and activity of the Na+,K+-ATPase was 
reduced by CO2. Elucidating the effect on the apical Na+-permeability alone revealed no 
significant differences in normocapnia- versus hypercapnia-treated cells during up to 20 
min.  
However, when cells where incubated in normocapnic versus hypercapnic conditions for 
24 hours, a marked decrease of the apical Na+-permeability was detected, suggesting an 
immediate effect of CO2 on the Na+,K+-ATPase and a delayed effect on ENaC in this 
system as postulated previously (Woollhead et al., 2007). Further experiments revealed 
that no change of mRNA-levels of all ENaC subunits occurred after 6 and 24 hour, 
pointing to a post-translational regulation as opposed to a change in gene-regulation. 
Unfortunately a pharmacological intervention with the AMPK-inhibitor Compound C even 
in a four fold lower concentration as published by others (Albert et al., 2008) and the 
proteasome-inhibitor MG-132 was not successful due to the much longer incubation times, 
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so there were no tools left to continue with functional experiments. Efficient transfection of 
H441 cells was not yet established so another system had to be used to study the effects of 
CO2 on ENaC.  
4.2. Molecular mechanism of CO2-regulated ENaC function 
The molecular basis of CO2-mediated ENaC regulation was characterized in A549 cells. 
These cells are derived from a human alveolar cell carcinoma and contain multilamellar 
cytoplasmic inclusion bodies and secrete surfactant similar to primary ATII cells (Lieber et 
al., 1976). A549 cells are not ideal for functional alveolar epithelial barrier studies, for 
example Ussing chamber experiments, since they exhibit low transepithelial electrical 
resistance due to a reduced synthesis of tight-junction proteins such as zona-occludens 
protein-1 (ZO-1) (Lehmann et al., 2011). But an extended range of mechanistic 
experiments is possible with this system, since genetic manipulation can be done easily.  
In the present study A549 cells were used as recipients for epitope-tagged ENaC plasmids, 
since endogenous ENaC-proteins are difficult to detect using standard western blot 
techniques. In initial suudies, only the human β-ENaC was cloned and modified with a 
small epitope V5-tag of the paramyxovirus of simian virus 5 (SV5) for better antibody 
recognition. Some evidence from the literature suggests, that regulation of only β-ENaC 
might be sufficient for a modulation of ENaC-function: In the human embryonic kidney 
cell line (HEK-293) activation of AMPK increased only the interaction of β-ENaC with 
Nedd4-2, leading to reduced Na+-transport (Bhalla et al., 2006). Further, overexpression of 
β-ENaC alone, but not α or γ in the mouse led to increased fluid reabsorption (Mall et al., 
2004). Thus the rationale of the experiments described now was to produce an ENaC 
subunit that could be detected easily and to generally increase the protein levels of all 
ENaC subunits in the plasma membrane.  
To investigate effects of hypercapnia, transfected cells were exposed to normocapnia and 
hypercapnia for 1 and 24 hours and the membrane as well as the whole cell abundance of 
β-ENaC was determined. In line with the Ussing chamber experiments no change of β-
ENaC was detected after short term exposure to CO2. After 24 hours of CO2 a marked 
decrease of β-ENaC in the cell membrane was observed that was not paralleled by a 
decrease of total β-ENaC levels.  
Also in line with the Ussing chamber experiments interference with the CO2 induced 
signaling cascade using different drugs in β-ENaC expressing A549 cells was not 
successful. Overexpression of single ENaC subunits compared to overexpression of the full 
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αβγ-ENaC might interfere with posttranscriptional modification and trafficking as reported 
by Hughey et al. for Chinese hamster ovary (CHO) and Madin-Darby canine kidney type 1 
(MDCK) cells (Hughey et al., 2003). To rule out effects of hypercapnia on the pore-
forming α- and the regulatory γ-subunit and effects that were limited to the fully functional 
ENaC complex, plasmids encoding these proteins modified with individual tags for the N- 
as well as the C-terminus were generated.  
The coding sequence for α-ENaC contained the two single-nucleotide polymorphisms 
A334T and T663A that were corrected before starting the actual experiments. Both 
polymorphisms are known, but especially T663A was important to correct, since 
degradation and activity of both polymorphisms seem to be different. A334T does not 
appear to change the physiologic properties of the channel (Tong et al., 2006; Yan et al., 
2006). As demonstrated in the present study both polymorphisms have no effect on the size 
and posttranscriptional processing of α-ENaC. 
Next, all three ENaC subunits were cotransfected in A549 cells. β-ENaC could be detected 
best, but the α- and the γ-subunit were hardly detectable, especially in the membrane. Now, 
the ENaC subunits could be recognized by antibodies, but the expression level was 
extremely low and in most cases below the detection limit. In the kidney cell lines COS-7 
and HEK-293 it has been demonstrated, that ENaC subunits form a complex that is largely 
insoluble in conventional detergent-based cell lysis buffers and that ENaC detection was 
largely improved, when the detergent-insoluble fraction was denatured in SDS and β-
mercaptoethanol containing buffer at 90 °C (Prince and Welsh, 1998). Also a trafficking of 
ENaC into lipid rafts in kidney cells of the mouse was reported, although the ratio of 
insoluble ENaC was smaller in that study compared to detergent-insoluble proteins (Hill et 
al., 2007).  
In this study, the detergent insoluble fraction of the cell lysate of A549 cells was denatured 
as published previously (Prince and Welsh, 1998), but an insoluble complex composed of 
αβγ-ENaC could not be detected. Also an incorporation of α-ENaC alone into lipid rafts 
that are solubilized by the protocol used could not be shown, indicating that differential 
solubility might be a feature of ENaC that is limited to renal cell lines.   
Coexpression of all three ENaC-subunits in A549 cells was not succesful. To test whether 
α-ENaC alone would be regulated during hypercapnia the half-life of α-ENaC located in 
the plasma membrane was determined by pulse chase experiments which revealed a half-
life of about two hours. Next, the stability of α-ENaC located in the membrane was 
compared during normocapnia and hypercapnia in which a clear trend to reduction in 
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hypercapnia, compared to normocapnia, was evident, although no statistical significance 
was apparent.  
Since the stability of ENaC is described to be markedly affected by its ubiquitin ligase 
Nedd4-2 (Kabra et al., 2008; Rotin and Staub, 2012; Staub et al., 2000) a genetic approach 
was chosen in which Nedd4-2 was downregulated by siRNA in A549 cells. α-ENaC was 
transfected two days later, to match its maximal expression with the time of best 
knockdown of Nedd4-2. Baseline degradation seems not to be critically dependent on 
Nedd4-2, since about 60 % of α-ENaC located in the membrane was degraded within four 
hours independently of the presence of Nedd4-2.  
To sum up all experiments involving hypercapnia and A549 cells: β-ENaC is down 
regulated after sustained hypercapnia by an unknown posttranslational mechanism, 
whereas α-ENaC might already be affected earlier, but definitive evidence is missing. 
Nedd4-2 does not seem to play an important role in ENaC degradation in A549 cells, 
neither under normal conditions nor during hypercapnia, at least not in the conditions that 
were used in this study. 
4.3. Transfection of H441 cells – Seeking the right system 
After the addition of the 27 kDa eYFP tag, the full size α-ENaC has a predicted size of 
about 120 kDa and two fragments of approximately 60 kDa when cleaved. Interestingly, 
only the bigger of the two detected bands (~ 100 and 120 kDa) for α-ENaC matched the 
predicted size. To complement the experiments that were performed in A549 cells, another 
cell line was used for further studies. 
An alternative for A549 cells as recipients for genetically modified ENaC constructs are 
H441 cells. As mentioned above these cells were used for functional studies of ENaC 
activity, but transfection has been difficult and its efficiency in H441 cells has rarely been 
published. Low efficiencies of 5 – 10 % were achieved by Polyfect transfection agent 
(Lazrak et al., 2009). Virus-mediated gene transfer has been reported to work very well, 
since lentiviral transduction reached an efficiency of up to 100 % (Aarbiou et al., 2012). 
But virus mediated gene transfer is associated with strict safety regulations and it is very 
time and labour intensive.    
In the present study, a non-viral protocol was established to transfect H441 cells by 
Nucleofection. As shown by fluorescence microscopy and flow cytometry about 60 % of 
H441 cells expressed the eGFP encoded in the transfected control plasmid.  
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Using the generated ENaC plasmids encoding αβγ-subunits it was possible to transiently 
coexpress all three subunits in the same cells. Surprisingly the cleavage pattern of the α-
subunit (~ 45 and 130 kDa) was different from the one seen in A549 cells (~ 100 and 120 
kDa), although the exact same plasmid was used for transfection. The predicted sizes for 
the eYFP-tag containing cleaved and full length forms are ~ 60 and 120 kDa based on the 
observations from Hughey and Carattino (Carattino et al., 2006; Hughey et al., 2004), so 
the pattern found in H441 cells hints more to a proteolytically activated form of α-ENaC. 
Also the cleavage pattern of the γ-subunit was close to the predicted sizes of 76 and 97 
kDa, indicating that the posttranslational processing of ENaC in H441 cells was more 
likely to function properly compared to A549 cells. However, membrane expression in 
H441 cells especially of the α- and γ-subunit was extremely low, close to the detection 
limit, although large amounts of proteins were used for the pulldown. Despite extensive 
effort on optimization the system could not be fully applied to mechanistic experiments.        
Identification of ENaC on the protein level and its interpretation is generally difficult. 
Results vary widely dependent on the type of cells that is used and the culture conditions. 
And even in the same cell type the sizes for ENaC subunits can be different. Possible 
explanations are different states of glycosylation and proteolysis. A brief overview about 
endogenous ENaC sizes that have been published is provided in Table 24.  
Many investigators use overexpression of hetero- or homologous ENaC subunits, thus 
complicating the comparison of different studies. Westernblot results vary from many 
nonspecific bands and smears (Bhalla et al., 2006) to a single band for all forms of  
cotransfected αβγ-ENaC modified with the same epitope tag (Lee et al., 2009).  
 
Table 24 Reported sizes [kDa] of endogenous ENaC in different cell types (n.d.: not detected) 
Cell type Species α  β  γ Publication 
ATI/II Rat 180-200   (Johnson et al., 2002) 
H441 Human 65 / 67; 90-100 88  (Albert et al., 2008) 
ATII Rat 60; 90   (Frank et al., 2003) 
ATII Rat 65; 70-75; 97; 150 n.d. 150 (Lazrak et al., 2012) 
A6 Xenopus < 90 90 95 (Eaton et al., 2010) 
A6 Xenopus 75; 150; 180 97 95 (Weisz et al., 2000) 
A549 cells Human 100; 120 100   present work 
H441 Human 45; 130 100 76; 100  present work 
ATII Rat 120 100 n.d.  present work 
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4.4. Novel technique for transfection of primary alveolar epithelial 
cells 
A549 and H441 cells are both immortalized cell lines that resemble alveolar epithelial 
cells, but show clear differences to freshly isolated primary cells (Lieber et al., 1976; 
Ramminger et al., 2004). So the most physiologic attempt to study the function of alveolar 
epithelia would be to use primary cells.  
To combine the generated ENaC constructs with the advantage of primary cells, a novel 
technique was established to genetically manipulate primary rat alveolar epithelial type II 
(ATII) cells.   
ATII cells are hard to transfect. This is basically due to two reasons: Primary alveolar cells 
do not proliferate, at least not to a significant extent and contain large amount of 
multilamellar bodies.  
Only a very small fraction (0.5-1 %) of freshly isolated ATII cells has been reported to be 
proliferative (Kalina et al., 1993). Many transfection methods are based on the exposure of 
the nuclear machinery to the cytosol during mitosis (Kirton et al., 2013). One example that 
was also used in this thesis for A549 cells is lipofection, a lipid based transfection 
procedure that works well in rapidly dividing cell lines. This technique incorporates 
nucleic acids into liposomes that fuse with the cell membrane, thereby releasing the nucleic 
acids into the cytosol (Felgner et al., 1987). As shown in the present thesis the transfection 
rate by Lipofection is minimal. 
Further, ATII cells contain a large amount of lamellar bodies. Even if siRNA or cDNA can 
be delivered to ATII cells, it is trapped and unable to translocate into the nucleus (Friend et 
al., 1996).  
Two publications suggest that freshly isolated ATII cells take up “naked” siRNA without 
any additional treatment (Jain 1999, Jain 2001), but this technique has not been applied and 
published any further.  
Adenovirus mediated gene transfer, the only efficient way to deliver nucleic acids to ATII 
cells, has been reported by several investigators (Berger et al., 2011; Factor et al., 1998; 
Roux et al., 2005; Vadász et al., 2012). The transfection efficiency ranges somewhere 
around 50 – 60 %. But virus infection is associated with increased safety regulations and 
the preparation of the reagents is expensive and time consuming.  
During the present study, an innovative transfection method has been established for ATII 
cells. The process called Nucleofection is based on electroporation and combines special 
nucleofection solutions with distinct electrical pulses to drive nucleic acids directly into the 
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nucleus of hard-to-transfect cell lines (Gresch et al., 2004). The best combination is 
specific for each cell type and has to be determined empirically.  
For optimization purposes an GFP expressing vector was used, so that the successfully 
transfected cells could be identified by flow cytometry and fluorescence microscopy. After 
optimization the transfection efficiency was approximately 50 %. The determination of the 
transepithelial electrical resistance showed no significant reduction of monolayer integrity 
of transfected compared to untransfected cells. Immediately after Nucleofection a transient 
release of lactate-dehydrogenase was observed in cells that received the electrical pulse. 
This LDH release was limited to the transfection procedure and can be explained by the 
formation of pores in the cell membrane that enable entry of nucleic acids (Gresch et al., 
2004). LDH release one day after Nucleofection showed no increased cell damage and also 
determination of viability two days after Nucleofection was not different from control cells 
as assessed by flow cytometry, indicating that the described procedure does not interfere 
with cell viability.     
Nucleofection of rat ATII cells has already been published before, but the transfection 
efficiency for cells harvested from adult animals, as in the present study, was only ~ 13 %. 
The authors were using an earlier device and different solutions and electrical pulses 
(McCoy et al., 2006). The present study, which has been recently published in part 
(Grzesik et al., 2013), demonstrates for the first time highly efficient transfection of 
primary rat alveolar epithelial type II cells and thus represents an important advance in 
studying physiology of primary alveolar epithelial cells. The non-viral procedure is highly 
efficient, non-cytotoxic, fast and since the electrical properties of the plated cells were not 
impaired, which indicates that nucleofected ATII cells can be used in a variety of 
experimental settings, including electrophysiology.  
The newly established Nucleofection protocol was finally used to transfect ATII cells with 
ENaC subunits. For convenience, the already described commercially available α- and γ-
ENaC constructs (Origene) were used. Preliminary results show that the cell surface 
abundance of at least α- and β-ENaC are drastically increased in ATII cells, compared to 
H441 cells. Thus, Nucleofection of epitope tagged ENaC-subunits into ATII cells could be 
the solution to overcome the poor detectability and low expression levels of ENaC in other 
systems.  
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5. Summary 
Acute respiratory distress syndrome is a life threatening condition triggered by a variety of 
pulmonary and extrapulmonary causes, that is characterized by pulmonary edema and 
subsequently impaired gas exchange. Due to lung protective ventilation strategies, its 
treatment is often associated with systemic accumulation of CO2, a condition termed 
permissive hypercapnia. Recent studies report a negative effect of CO2 on alveolar fluid 
clearance, a process mediated by its two key elements the Na+,K+-ATPase and epithelial 
Na+-channels (ENaCs). A reduced activity of the Na+,K+-ATPase during hypercapnia has 
already been demonstrated, but regulation of ENaC has never been directly linked to CO2. 
Many molecular signaling events that are activated during hypercapnia are known to 
regulate ENaC function, so the present study aimed to generate and subsequently apply 
techniques to investigate a possible contribution of ENaC to the reduction of alveolar 
epithelial fluid transport upon hypercapnia. 
ENaC function was studied in H441 cells  by Ussing chamber experiments which revealed 
no significant regulation during short term hypercapnia, but a clear reduction of ENaC 
function during sustained hypercapnia.  
To identify the signaling mechanism on the molecular level, epitope-tagged human ENaC 
constructs for the α-, β- and γ-subunit were cloned and initially expressed in A549 cells. 
Exposition to hypercapnia up to 4 hours did not significantly reduce cell surface expression 
of the ENaC-subunits, but after 24 hours, a significant decrease of β-ENaC was observed. 
Since the molecular sizes of α- and γ-ENaC expressed in A549 cells were differing from 
previously published studies, transfection of ENaC was continued in other cells. H441 cells 
are commonly used for ENaC studies, so their transfection was established, yielding an 
efficiency of about 60 %. The molecular sizes of transfected ENaC subunits matched the 
pattern that was expected, but expression levels were evanescent and too low for further 
experiments. Since ENaC detection in these two cell lines remained problematic, a novel 
methodology was applied. Since the primary site of ENaC expression in the lung are 
epithelial cells, rat primary alveolar epithelial cells type II were used as recipients for 
ENaC plasmids. Non-viral transfection of ATII cells has been inefficient in the past, but 
during the present study a protocol was generated to efficiently deliver nucleic acids to 
exactly this cell type. ENaC expression was largely increased in ATII cells, compared to 
the cell lines used, indicating that established system might be extremely useful for further 
studies involving ENaC turnover. 
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Thus, a new and highly relevant, non-viral transfection technique for primary alveolar 
epithelial type II cells was established, providing ground-breaking opportunities for future 
pulmonary research. 
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6. Zusammenfassung 
Das Atemnotsyndrom des Erwachsenen ist eine lebensbedrohliche Erkrankung,  ausgelöst 
durch eine Reihe von Faktoren, die direkt oder indirekt auf die Lunge einwirken . 
Charakteristisch für dieses Syndrom sind pulmonare Ödeme und daraus resultierend ein 
eingeschränkter Gasaustausch. Die daher benötigte künstliche Beatmung führt im Zuge 
von protektiven Beatmungsstrategien oft zu einer systemischen Anreicherung von CO2 
(Hyperkapnie). Einige Studien zeigen, dass erhöhte CO2-Level den Flüssigkeitstransport 
der Lunge einschränken. Dieser aktive Prozess wird maßgeblich durch zwei Komponenten, 
die Na+,K+-ATPase und epitheliale Na+-Kanäle (ENaCs), kontrolliert. Eine 
Beeinträchtigung der Na+,K+-ATPase durch CO2 gezeigt, für ENaCs ist dies bislang nicht 
bekannt. Einige bekannte Regulatoren von ENaCs werden jedoch während Hyperkapnie 
aktiviert. Das Ziel der vorliegenden Arbeit war, Methoden zu etablieren und anzuwenden, 
die einen möglichen Einfluss von CO2 auf ENaC zeigen. 
Funktionelle Versuche wurden an H441-Zellen mit Ussing-Kammer-Messungen 
durchgeführt. Während akuter Hyperkapnie konnte keine signifikante Regulation von 
ENaC nachgewiesen werden, jedoch war die ENaC-Funktion bei anhaltender Hyperkapnie 
deutlich verringert. 
Um die Signalwege auf molekularer Ebene zu untersuchen, wurde die α-, β- und γ-
Untereinheit des humanen ENaC kloniert, genetisch modifiziert und in A549 Zellen 
überexprimiert. Nach bis zu vierstündiger Hyperkapnie erfolgte keine Regulation von 
ENaC, jedoch wurde nach 24 Stunden eine deutlich verminderte Menge β-ENaC in der 
Zellmembran nachgewiesen. Da die Größen von α- und γ-ENaC von den bisher 
publizierten abwichen, wurden weitere Versuche in H441 Zellen durchgeführt. Die 
Transfektion dieser Zelllinie wurde etabliert und erreichte eine Effizienz von ungefähr 60 
%. Die posttranslationale Regulation der α- und γ-Untereinheiten, insbesondere die 
proteolytische Aktivierung funktionierten wie in der Literatur beschrieben, jedoch waren 
die Expressionslevel zu gering für weitere Versuche. In der Lunge werden ENaCs 
überwiegend in epithelialen Zellen exprimiert. Diese Zellen konnten bisher jedoch nicht 
effizient transfiziert werden, ohne Viren einzusetzen. In der vorliegenden Arbeit wurde 
jedoch eine effiziente Methode zur Transfektion von primären epithelialen Zellen der Ratte 
erarbeitet. Die Expression von transfizierten ENaC-Untereinheiten war in diesen Zellen 
deutlich erhöht, weswegen die  Etablierung dieses Systems ausschlaggebend für weitere 
Versuche ist. 
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Die vorliegende Arbeit beschreibt daher zum ersten Mal die nicht-virale, effiziente 
Transfektion von primären alveolaren Zellen und liefert damit ein bedeutendes neues 
Werkzeug für die Lungenforschung. 
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